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CHAPTER I: STATEMENTOFTHEPROBLEM
Background and Significance
Tobacco use is the leading preventable cause of death, disease, and disability in the U.S .
Each year, around 443,000 people die from smoking or exposure to secondhand smoke, and
another 8.6 million suffer from a serious illness from smoking. There have been several
recommendations and implications for physicians and other healthcare professionals to play a
central role in motivating and assisting patients who smoke to quit (Fiore, M et al., 2008).
Healthcare providers are a credible and trusted source of advice to quit, have opportunities to
provide this message to most smokers, and can connect patients to cessation counseling and
pharmacotherapy. These actions are economical and effective at increasing cessation rates
(Macosek, 2006).
About I in 5 adults smoke (45.3 million) and, although smoking prevalence has declined
from 20.9% in 2005 to 19.3% in 2010, tobacco use is still the most common cause of preventable
death and disease in the United States (Centers for Disease Control and Prevention, 2010).
Smoking reduces the median survival of smokers on average by 10 years, and beyond the age of
40, each additional year of smoking reduces life expectancy by three months (Doll, 2004). By
stopping cigarette smoking, a patient reduces the risk of lung cancer and other diseases by up to
90 % and improves survival, even if cessation occurs after the age of 50 years. Nonetheless,
habitual smokers find it extremely difficult to successfully stop smoking. Although 70 % of
smokers would like to quit, and 40 % make at least one stopping attempt per year, only three to

four percent of smokers per year are successful in stopping long-term on their own (Messer,
2007). The highest risk for relapse is within the first eight days after quitting. Active smoking
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cessation interventions by the physician, a clinic staff member, or a counseling service (inservice or telephone counseling) should be initiated before or within the initial week after the
planned quit date (Hughes, 2004).
As a result of tobacco use, primarily cigarette smoking, which is the leading cause of
preventable morbidity and mortality in the United States (Mokdad, Marks, Stroup, Gerberding,
2004), primary care providers have an opportunity to offer office-based smoking cessation
interventions to the 70 % of smokers who visit their offices every year (Fiore., 2002). Primary
care providers are in a strategic position to help their patients quit smoking. It has been estimated
that at least 70 % of smokers see a physician each year, and 70 % also report a desire to quit and
make at least one serious attempt to do so (Lancaster, Stead, 2004). In addition, smokers cite a
physician's advice to quit as an important motivating factor for attempting to quit; brief advice
from a physician leads to a spontaneous quit rate of two to four percent (Lancaster, Stead, 2004).
The National Cancer Institute estimates that if 100,000 physicians were to assist ten percent of
their patients who smoke to quit each year, the number of smokers in the United States would
decrease at a rate of two million people annually (Ockene, 1987).
Healthy People 2020 provide science-based, national goals and objectives with ten-year
targets designed to guide national health promotion and disease prevention efforts to improve the
health of all people in the United States. The Healthy People 2020 Tobacco Use objectives are
organized into three key areas. The first is the Tobacco Use Prevalence, which involves
implementing policies to "reduce tobacco use and initiation among youth and adults"
(CDC.gov). Providing educational tools in the school system to encourage cessation,
particularly at the middle and high school levels, has been an implementation at the local Health
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Departments across the state of Tennessee. The second is the Health System Changes, which is
"adopting policies and strategies to increase access, affordability, and use of smoking cessation
services and treatments" (CDC.gov). The ability to access information from the CDC website
and acquire brochures, handouts, and website information to view, plus educating at the point of
care has been utilized and proven efficacious in the local Health Departments here in Southeast
Tennessee. Social and Environmental Changes is the third objective by "establishing policies to
reduce exposure to secondhand smoke, increase the cost of tobacco, restrict tobacco advertising,
and reduce illegal sales to minors" (CDC.gov). Each objective includes a nationally
representative and reliable data source, baseline estimate, and target for specific improvements to
be achieved by the year 2020 (CDC.gov).
Wadland et al, demonstrated that physicians and their staffs can be trained to
successfully deliver office-based smoking cessation interventions and that these interventions
significantly improve smoking cessation rates (Wadland, Stoffelmayr, Berger, Crombach, Ives.
Enhancing, 1999, Katz, Muehlenbruch, Brown, Fiore, Baker, 2005). Meta-analyses of
randomized trials have found a strong dose-response relationship between the duration of
counseling (both number of sessions and length of each session) and abstinence rates
(Fiore et al., 2008). Clinician counseling sessions greater than ten minutes more than double the
rate of abstinence compared to no counseling. Clinician counseling may consist of multiple
visits, often weekly, starting before the quit date and continuing for one to two months after the
quit date to optimally support a smoker through the quitting process. These programs are more
effective than simple self-help interventions, in which smokers are provided with take-home
print or audiovisual material to aid them in quitting on their own (Coleman, 2004). Self-help
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interventions have proven to be ineffective when offered alone, although take-home materials
can augment the efficacy of clinician counseling (Landcaster, 2005).
Currently, Utah has the lowest smoking rate; fewer than ten percent of adults in Utah
smoke cigarettes. Kentucky and West Virginia have the highest smoking rates; nearly 26% of
adults smoke in both states. Fewer people smoke in the West (about 16%), and more people
smoke in the Southeast (about 22%) and Midwest (about 23%) (cdc.gov/vital signs/Tobacco
Use/Smoking/index.html).
Most individuals with an addiction to cigarettes started smoking before they turned 18
years old. Tennesseans under the age of 18 will purchase and consume over 16.8 million packs
of cigarettes this year (www.tobaccofreekids.org). Approximately 7,600 young people in
1'ennessee become new )'outb smokers each )'ear, and L\\2,l)l)l) oftoda)''s 1'ennessee cb\\dren
will become smokers; 132,000 of them will die prematurely from tobacco related causes
(www.tobaccofreekids.org). Unfortunately, most of the patients seen in the primary care setting
in Southeast Tennessee, those who are uninsured or underinsured, already smoke and have
negative repercussions from their years of tobacco use.
The once commonly held belief that smoking tobacco was harmless, and perhaps even
good for some, was shattered on January 11, 1964. The first U.S. Surgeon General's report on
smoking was issued that day, alerting Americans, and the world, to the deadly consequences of
smoking. In the 50 years since that report, the U.S. and Tennessee have made remarkable
progress, cutting smoking rates significantly, protecting much of the population from harmful
secondhand smoke, and saving millions of lives. Still, the battle against tobacco is far from won,
and too many people develop or sustain addictions to tobacco products.
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"Tobacco use kills more than 440,000 Americans, including 9,700 Tennesseans, every
year; it sickens millions more and costs Tennessee $2.6 billion of the nation's $193
billion in healthcare bills and lost productivity," said Tennessee Department of Health
Commissioner John Dreyzehner, MD, MPH. "Our state is near the bottom, 47th, in
smoking rates with a quarter of all adults and more than one in five high school students
currently smoking. This is terrible. We can and must do a better job in preventing young
people from starting an addiction to nicotine, preventing children and others from being
exposed to harmful secondhand tobacco products, and encouraging people to quit through
programs like 1-800-QUIT-NOW"
(Media Release: http://news.tn.gov/taxonomy/term/30, January 14, 2014).
Officials with the Centers for Disease Control and Prevention say the tobacco industry
spends eight billion dollars annually, or nearly one million dollars per hour, on marketing and
recruiting two new young smokers for every adult who dies from tobacco-related illness. That
equates to about $28 per U.S. resident per year. The CDC also reports that states collect about
$80 per person per year in tobacco taxes and settlement funds but only spend, collectively, about
$1.50 per year per person on tobacco prevention (cdc.gov). Up to one-half of all tobacco users
can be expected to die from a tobacco-related disease. The economic burden of tobacco use is
estimated to be $197 billion per year, which includes $96 billion in health care costs and an
additional $97 billion in productivity losses (World Health Organization Report on the Global
Tobacco Epidemic, 2011 ).
The most important causes of smoking-related mortality are atherosclerotic
cardiovascular disease (CVD), lung cancer, and chronic obstructive pulmonary disease (COPD)
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(CDC - MMWR 2009). Tobacco use also increases the risk of many other acute and chronic
diseases, including cancers at many sites other than the lung. An estimated 30 % of cancers in
the US are tobacco-related (US Department of Health and Human Services, 2005). Smoking
cessation is associated with clear health benefits and should always be a major health care goal.
Screening all patients for tobacco use and providing all smokers a brief smoking cessation
intervention is one of the three most cost-saving clinical preventive services (Maciosek, et al.,
2006).
Tennessee and many other states are using the 50th anniversary of the Surgeon General's
report on tobacco to emphasize three shared national goals: l) Reduce smoking rates to less than
ten percent within ten years; 2) to protect all Americans from secondhand smoke within five
years; and 3) ultimately eliminate death and disease caused by tobacco. The mission of the
Tennessee Department of Health is to protect, promote and improve the health and prosperity of
people in Tennessee (http://health.state.tn.us/).

Prevalence and Tobacco use Patterns
The prevalence of smoking cigarettes among Unites States (US) adults has declined from
42.4 % in 1965 to 19.3 % in 2010 (CDC Report, 2011 ). However, there has been little decline in
adult smoking prevalence since 2005 in contrast to the dramatic declines of past decades. Not all
smokers are daily smokers; 78 % of smokers smoke every day while 22 % smoke less frequently
than daily (CDC Vital Signs, 2009).
The pattern of tobacco use in the U.S. varies among socio-demographic groups. A large
gender gap in cigarette smoking existed in the 1960s, when over 50 % of men and only about
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25 % of women smoked. This gap has narrowed but not disappeared. Currently, 21.5 % of men
and 17.3 % of women smoke cigarettes (CDC Vital Signs, 2011).
Today, the largest disparities in tobacco use occur in groups defined by education,
income, race, and ethnicity. More than one-quarter (28.4 %) of individuals without a high school
diploma smoke cigarettes, compared to only 11.1 % of adults with a college degree. Individuals
who have passed the General Education Development (GED) tests smoke at an even higher rate
(49.1 %) than those without a high school diploma. The CDC also notes current statistics
regarding adults with education levels at or below the equivalent of a high school diploma, who
comprise nearly half of current smokers, which have the lowest quit ratios 39.9 to 48.8 % (CDC
Vital Signs, 2011 ).
Adults with incomes below the federal poverty level are significantly more likely to
smoke than adults with higher incomes (28.9 versus 18.3 %) (CDC-Vital Signs. MMWR,
2007). Among racial and ethnic groups, smoking prevalence is similar between Caucasians
(22.1 %) and African-Americans (21.3 %) and is lower among Hispanics (14.6 %) and Asians
(12.0 %). Many current smokers are trying to quit. Forty percent of daily smokers report that
they did not smoke for more than 24 hours in the past year because they were trying to quit. This
rate is even higher among young adult smokers (aged 18 to 24 years), over half of whom made a
quit attempt in the past year (Centers for Disease Control and Prevention (CDC). Vital signs:
current cigarette smoking among adults aged >or=l8 years --- United States, 2009. MMWR
Morbidity Mortal Weekly Rep 2010; 59:1135).
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Patterns of tobacco use
Turner (2007) concluded his research and noted that almost every adult who currently smokes
started smoking by the age of 18. Half of high school students have tried smoking a cigarette, 20
% have smoked a cigarette in the past 30 days, and 8 % smoked frequently, defined as smoking

on 20 of the past 30 days (CDC, 2008). Past-month smoking rates among twelfth-grade high
school students increased during the 1990s, peaking at 36.4 % in 1997, and have since declined
to 20 % (CDC 2008).
The earlier the age at which a person begins smoking, the more likely he or she is to
continue into adulthood (Maciosek, Coffield , Edwards, et al., 2006). Within a year of smoking
initiation, children inhale the same amount of nicotine per cigarette as adults and experience the
craving and withdrawal symptoms, and, unfortunately, tobacco dependence can develop very
quickly in children (DiFranza, Savageau, Fletcher, et al., 2007), although the amount smoked
may increase for a number of years. By the time they are 20 years old, 80 % of young smokers
regret ever having started (Jarvis, 2004).
Risk factors for an adolescent becoming a smoker include having parents or friends who
smoke, living with a smoker, having a strained relationship with a parent and/or single parent at
home, low level of self-esteem and self-worth, poor academic performance, increased perception
of parents' approval of one's smoking, comorbid psychiatric disorders, and the availability of
cigarettes (Maciosek, Coffield, Edwards, et al., 2006). An additional risk factor for boys is high
levels of aggression and rebelliousness, and for girls, preoccupation with weight and body image
is a separate risk factor (Maciosek, et al,. 2006). Studies that involved twins have shown a
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significant genetic link to both smoking initiation and dependence, although it is likely that they
involve different genes (Swan, 1999).
Nicotine Sources
In addition to cigarettes, tobacco is also smoked in the form of cigars, pipes, and waterpipes. Tobacco in the form of chewing tobacco and snuff is not smoked but is absorbed through
the buccal mucosal membrane. Electronic cigarettes (e-cigarettes) use a liquid nicotine cartridge,
rather than tobacco.
The smoke from cigars and pipes is not typically inhaled as deeply into the lungs as is
cigarette smoke and, for this reason, the risk of lung cancer from smoking cigars and pipes is
lower than the risk of smoking cigarettes, but higher than the risk of a nonsmoker
(www.cdc.gov/tobacco/sgr/sgr 2004/index.htm).
The use of water pipes (also known as hookah) to smoke tobacco is an emerging form of
tobacco smoking in the US, especially among young adults (Primack, Sidani , Agarwal, et al.,
2008). Currently, there is only one Hookah lounge located in Hixson, Tennessee. This is a
traditional form of tobacco use in the Middle East and the amount of nicotine and toxins varies
based on the type of tobacco used and how it is smoked. Water-pipe smoking is also associated
with lung cancer and other respiratory diseases (Akl, Gaddam, Gunukula, et al., 2010). One
meta-analysis of six cross-sectional studies found that waterpipe smoking negatively affects lung
function, particularly in reducing forced expiratory volume in one second (FEVl) and is likely to
be a cause of obstructive lung disease (Raad, Gaddam, Schunemann, et al., 2011 ).
Smokeless tobacco is available as chewing tobacco or snuff. Different processing
techniques, particularly "curing", can result in markedly different contents of toxins in smokeless
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products. About three percent of adults in the US use smokeless products, primarily white males
of lower socioeconomic status in the southern or western US. Smokeless tobacco is not
harmless, although the health risks for certain diseases may be substantially less than with
smoking. It may also cause cancer of the oral cavity and provides sufficient nicotine exposure to
cause nicotine addiction (Scientific Committee on Emerging and Newly Identified Health Risks.
Health effects of smokeless tobacco products. Available at
ec.europa.eu/health/ph_risk/committees/04_ scenihr/docs/scenihr_ o_ 013. pdf).
Electronic cigarettes ( e-cigarettes) use an electronic delivery system that aerosolizes
nicotine, producing a vapor similar to cigarettes but containing fewer traditional toxins (Yamin,
Bitton, Bates, 2010). E-cigarette devices are composed of three parts: a plastic tube, an electronic
heating element, and a liquid nicotine cartridge. The user presses a button that simultaneously
releases a puff of vaporized nicotine while illuminating the device tip (that simulates the lit end
of a cigarette). E-cigarettes do reduce the desire to smoke traditional cigarettes and have been
prescribed by clinicians to aid in smoking cessation (Bullen, McRobbie, Thomley, et al., 2010).
They are being increasingly used by the general population, mostly as a result of internet
advertising and sales. There are many available products that vary greatly in consistency, in
nicotine delivery, and in other additives that may have their own toxicity. A 2009 US Food and
Drug Administration (FDA) report one-cigarettes found trace amounts of the harmful solvent
diethylene glycol as well as nitrosamines which are known carcinogens. This report also found
nicotine in 'light' e-cigarettes that were labeled as being nicotine-free. The FDA has not
approved the use of any e-cigarettes given safety concerns, particularly related to use in
adolescents and potential toxic ingestion among children (fda.gov, 2010). Data from one pilot
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study reports common adverse effects of e-cigarettes as dry cough and irritation in the
oropharynx (Polosa, Caponnetto, Morjaria, et al., 2011 ). Whether initial recreational use of ecigarettes leads to smoking of conventional cigarettes is still unknown.
Despite their increasing popularity, little is known about e-cigarette use, potential for
addiction, or long-term health effects from smoking and second-hand smoke. Whether ecigarettes can help smokers to quit or permanently stop using tobacco products is uncertain
Rigotti, 2012). A randomized trial that compared e-cigarettes with nicotine patches among
smokers who wanted to quit found no significant difference in the cessation rates produced by
the two treatment arms, although the study was underpowered and could have missed important
differences in the effectiveness of e-cigarettes compared with patches (fda.gov, 2010). While this
trial suggests that e-cigarettes might have the potential to be smoking cessation aids, further
studies will be required to establish the efficacy and safety of e-cigarettes for cessation.

Purpose
The US Public Health Service Smoking Cessation Clinical Practice Guideline
recommends that all clinicians, including nurses, strongly advise their patients who use tobacco
to quit (Fiore, Bailey, Cohen, Dorfman, Goldstein, Gritz, et al., 2000).
The primary purpose of this doctoral scholarly project is to address the growing smoking
epidemic concern in the Southeast Region of Tennessee with adults aged 19 to 64 years who are
uninsured who seek care at the local health departments, specifically Sequatchie County Health
Department. A practice change is proposed and would entail a request for the addition of the
patient's current smoking status as an entity of the vital signs, and an assessment to determine
the current stage of change according to the Transtheoretical Model. Changing or modifying a
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behavior that is addictive or potentially harmful is difficult for most people. The Transtheoretical
Model (TTM) (Prochaska, Norcross, & DiClemente, 1994) incorporates a compilation of
previous theories, providing a framework for the stages of progression when deciding to change
a problematic behavior. The proposal would include an algorithm which would serve as a guide
for primary care providers (PCPs) encompassing the TTM, and would also comprise a
recommendation for the evaluation. These three components of the proposal would be in addition
to the already established Quit-line that is currently being utilized.
The goal of this practice change would be to provide improved patient care by increasing
provider's adherence to the recommendations of a clinical practice guideline for the assessment
and treatment of smoking cessation in the primary care setting.
Practice Setting
The setting for this study will be one of the primary care sites in the Southeast Regional
Health Departments, Sequatchie County Health Department. Primary care is provided at this
rural site where approximately 50-60 patients receive primary care weekly. The clinic's
population is largely made up of Caucasians as well as a small number of African Americans and
Hispanics. The majority of patients are between the ages of 19-65 years for primary care. The
clinic also provides Family Planning, provides services from a state run program for women,
infants and children (WIC), children with special needs (CSS), sexually transmitted infections
and diseases (STD).
The support of this scholarly project of addressing the growing epidemic concern of
smoking in the Southeast Region was initially discussed with the Southeast Regional medical
director who oversees all seven health departments of which only three currently provide
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primary care. For this doctoral project, the practice change emphasis will be focused on the three
primary care sites which are Sequatchie County Health Department in Dunlap, Grundy County
Health Department in Altamont and Bradley County Health Department in Cleveland,
Tennessee.

Definitions
Southeast Region Health Department
The Tennessee Department of Health is comprised of eight regions across the state of
Tennessee of which Southeast Region is one, which is further subdivided into counties including
Bledsoe, Bradley, Franklin, Grundy, Hamilton, McMinn, Marion, Meigs, Polk, Rhea, and
Sequatchie. The mission of the Tennessee Department of Health (TOH) is to protect, promote
and improve the health and prosperity of people in Tennessee. All 6.45 million Tennesseans,
along with those who visit our state, are touched directly or indirectly by TOH operations. One in
five, approximately 1.4 million people, are directly served each year through a network of 89
rural and six metropolitan county health departments. Others are affected by inspections of
restaurants, healthcare and related facilities; registration or receipt of vital records; protection
from communicable illness; licensing of health professionals; specialized laboratory testing and
many other services and programs.
Protecting people's health by preventing problems that contribute to illness, disease and
injury is the overall emphasis of the department. Contrary to popular belief of only
administration of immunizations at the Health Department, other crucial and indispensable
responsibilities include screening, providing and assuring a safety net of care, particularly in
medically underserved populations and areas of Tennessee; offering early prenatal care and
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proper nutrition to pregnant women and young children; and assuring restaurants, hotels, health
facilities and health professionals meet requirements and standards established in Tennessee
code. The regulatory work performed by the department impacts more than 10 % of Tennessee's
gross domestic product and more than 14 % of its workforce
(http:/!health.state.tn. us/ems/RegionalOffice.htm).
The greatest causes of premature death and preventable illness are closely related to the
way we live including what and how much we eat, whether we use tobacco, how much we
exercise, and what we do to protect our safety. The TDH emphasizes health protection, primarily
preventing illness and injury from occurring in the first place. By promoting healthy lifestyles
that avoid health risks and educating Tennesseans about the rewards we enjoy when we protect
the health of our communities, our families and ourselves, we are all able to enjoy better health.
QuitLine

The Tennessee Tobacco QuitLine is a toll-free telephone service that provides
personalized support for Tennesseans who want to quit smoking or chewing tobacco. When an
individual calls the QuitLine, they are assigned their own quit coach who then assists them in the
knowledge and understanding of how to quit using tobacco. Assistance in developing a
personalized plan that works for them plus the added advantage of having the same quit coach
for an entire year. The quit coach helps individuals figure out what works best for them. With
this program, the coach doesn't tell them what to do, but rather a collaborative effort is
encouraged with a quit coach to make changes that fit the individual's life. In addition to the
QuitLine at Sequatchie County Health Department, a smoking survey is completed on an initial
and annual visit to ascertain the patient's current usage of tobacco.
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Patient Tobacco Survey
The Patient Tobacco Survey is a six question multiple choice questionnaire with pointed
questions directly related to tobacco usage completed by the patient on initial and annual
appointments. This survey is completely voluntary and includes a 'refused' option as one of the
multiple choice answers. Patients are then questioned based on the answers on the questionnaire,
and then the provider has the opportunity to address their smoking cessation status
(Appendix A).

Health Promotion
Health promotion and disease prevention are essential competencies for nursing at the
doctorate of nursing practice level (American Associatiotvof Colleges of Nursing, 2006). Health
promotion is often cited as a distinguishing feature of nursing in comparison to the more disease
focused practice of physicians. It is the provision of services or implementation of processes that
advance health beyond simply preventing or eliminating illness to building capacity that enables
individuals and groups to improve their health and well-being (Hutchinson, et al., 2006;
Kiekbusch, 2003; Larson, 1999). Although health promotion and disease prevention are often
used interchangeably, their scope, underlying motivations, and purposes are unique. Health
promotion has a broad scope that encompasses the whole client, including bio-psychosocial,
cultural dimensions spiritual and the client's environment. Health promotion assists clients to
optimize health and well-being, attain balance, stability, and harmony, strengthen adaptation and
expand consciousness (M.P. O'Donnell, 1989, 2009,; Smith, 1990), Health promotion activities
include, but are not limited to, the prevention of disease or decreasing risk factors for disease
(Pender, Mardaugh, & Parsons, 2006; Smith, 1990).
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Program Evaluation
Program evaluation is the systematic inquiry of a program's activities, characteristics,
and outcomes to provide information for decision-making related to the program, to improve
program quality or effectiveness, or to inform future programs. Program evaluation is an
essential element of translating, sustaining, and improving health promotion programs. Various
approaches, models, and categories or types of evaluation serve as guides in conducting
evaluation projects. The selection of frameworks depends on the purpose of the evaluation, the
resources available, and planned use of the findings (Appendix F).
Five "A's"
The five "A''s are used to assess for tobacco use and address smoking cessation. The
interventions include:
•

Ask- Implement an office-wide system that ensures that, for every patient at every clinic
visit, tobacco-use status is queried and documented.
Advice- Strongly urge all tobacco users to quit in a clear, strong, personalized manner.
Assess- Determine the patient's willingness to quit smoking within the next 30 days.
Assist- Provide aid for the patient to quit.
Arrange- Schedule follow-up contact, either in person or by telephone. Follow-up contact
should occur soon after the quit date, preferably during the first week. A second followup contact is recommended within the first month. Schedule further follow-up contacts as
indicated. Congratulate success during each follow-up. If tobacco use has occurred,
review circumstances and elicit recommitment to total abstinence. Remind the patient
that a lapse can be used as a learning experience. Identify problems already encountered
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and anticipate challenges in the immediate future. Assess pharmacotherapy use and
problems. Consider use or referral to more intensive treatment (Fiore MC, Jaen C, Baker
T, et al., 2008).
Theoretical Framework
Health promotion and risk reduction are processes that advance health beyond simply
preventing or eliminating illness to building capacity that enables individuals and groups to
improve their health and well-being (Hutchinson et al., 2006; Kiekbusch, 2003; Larson, 1999).
Assessing, implementing, and evaluating strategies that affect health is a complex undertaking
that requires knowledge of comprehensive, logical, relevant theories and models. A theory has
been defined as an abstract generalization that offers a systematic explanation of how variables
are interrelated (Polit & Beck, 2008). Theories tell how and why things work and how and why
one variable is related to another. The Transtheoretical Model (TTM), CREATION, and the Self
efficacy theories are appropriate theories used to explain the phenomenon of interest of smoking
cessation in the primary care setting (Prochaska, 1992; CREATION Health, 2008; Bandura,
1986).
Transtheoretical Model (TTM)
Prochaska and DiClemente's stage of change model, the Transtheoretical Model (TTM),
is a contemporary psychological model of behavioral change employed to develop efficient
interventions to promote healthy behavioral changes. Interventions can be individualized to the
needs of individuals in order to achieve optimal results (Tang, Chen, & Chen, 2009). The TTM
emphasizes the importance of the readiness for change, hypothesizing that progress through the
stages of change is influenced by the pros and cons of changing, self-efficacy, cognitive and

PRACTICE CHANGE

22

behavioral processes (Prochaska, Redding, & Evers, 2002). The premise of the TTM is that a
behavior change is a process, not an event, influenced by motivation levels. It also outlines how
people make deliberate changes, especially eliminating problem behaviors and beginning new,
healthier behaviors. Behaviors generally progress from low awareness and no intention to
change, through high awareness and active efforts to initiate or maintain change. Behaviors also
emphasize the importance of the readiness for change, hypothesizing that progress through the
stages of change is influenced by the pros and cons of changing, self-efficacy, with cognitive and
behavioral processes (Prochaska, Redding, & Evers, 2002).
According to Prochaska ( 1994) the TTM behavior change is seen as a process that progresses
from low awareness and no intention to change, through high awareness and active efforts to
initiate or maintain change The first stage of the TTM is:
Pre-contemplation which is characterized as not currently considering change. During
this stage, individuals validate their lack of readiness. Clarification of decision making is
discussed, and re-evaluation of current behavior and self-exploration are encouraged.
The second stage is Contemplation where individuals are ambivalent about the
impending change or perhaps recognition of the problem and serious thought about the
changes are evident.
Preparation is the third phase where there is a conscientious decision to change within a
timeframe of one month. There may be some experience with change where persons are
trying to change and assistance in problem solving regarding obstacles may need to be
investigated and explored.
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Action or practicing the new behavior for approximately three to six months is the

characteristics of this forth stage of change. The techniques implemented here focus on
restructuring cues and social support, bolstering self-efficacy for addressing obstacles and
combating feelings of loss.
The fifth stage of change is maintenance where there is a continued commitment to
sustaining the new behavior for greater than six months. The techniques involved in this
stage of change include a plan for follow-up support, and the discussion of coping with
the potential of relapse (Prochaska, Redding, & Evers, 2002).
At the three primary care sites, each of the above mentioned five stages of change will be
proposed to be included in the vital signs component section of the progress notes. Interventions
may then be individualized to the needs of individuals in order to achieve optimal results.
CREATION Health Model

Florida Hospital is a Christian, faith-based hospital that believes in providing Whole
Person Care to all patients - mind, body and spirit, through the principals of CREATION Health.
CREATION Health is God's plan for living. This wellness program is based on Biblical
principles found in the Creation story and supported by evidence-based science. Learn the best
practices of whole person living - mentally and physically along with a strong focus on
spirituality and faith. CREATION Health is the 8 principle acronym that defines the way Florida
Hospital provides Whole Person Care to all patients-mind, body and spirit (CREATION
Health.com).
Choice is the first step toward improving one's wellbeing according to the CREATION
model (2011 ). Before one can achieve positive changes in any area of their lives, they must
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choose to do so. Conscious decision-making is fundamental and essential to experiencing the
positive impact of good choices. Deci, Speigel, et al ( 1982) state that providing one with the
ability to choose increases an individual's sense of personal control and feelings of intrinsic
motivation. The authors concluded that choices have powerful motivating consequences and
conversely, the absence of choice and control has a variety of detrimental effects on intrinsic
motivation, life satisfaction, and one's wellbeing. Ultimately, smokers have the innate ability of
choice to be exercised and applied.
Other entities of the CREATION model that could be relevant are Outlook, Nutrition
and Interpersonal relationships which may be directly applied and appropriated in the primary
care setting. Outlook refers to how individuals view the world, their lives, and their circle of
influence. Outlook also impacts everything one thinks about and does and is essentially a
person's general attitude. Seligmnan ( 1998) studied the effects of optimism and pessimism and
concluded that becoming an optimist consists of simply learning a set of skills about how to talk
to oneself when suffering a personal defeat and as the optimism increases, addressing setbacks
will be accomplished from a more encouraging perspective. In the primary care setting, outlook
may be perceived from the practitioner's encounter which may be a valuable entity in assessing
the stage of change regarding smoking cessation.
Nutrition is one of the most powerful tools we have to promote health and by so doing we
can substantially increase disease prevention and be healthier, happier and more energetic
(Willett, 1994). Science has demonstrated that fruits and vegetables are incredible promoters of
harmonious living. A study done on Chinese women in Singapore- a city in which pollution
levels are often high- showed that in non-smokers, eating cruciferous vegetable lowered their
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risk of lung cancer by 30%. In smokers, regularly eating cruciferous vegetables reduced lung
cancer risks an amazing 69% (Zhoa, Seow, et al., 2001). Incorporating a healthy, balanced diet
including nuts, seeds, whole grains, large amounts of water to maintain a well hydrated body,
and consuming breakfast daily are wise decisions that individuals can make about nutrition
which can have rich health rewards (CREATION, 2011). The need to introduce to some
smokers and encouraging others toward a healthy balanced diet during encounters in the primary
care setting, could potentially be a positive entity for smoking cessation.
Social connectedness and health have been recognized and evaluated in Dr. Dean
Omish's intervention for reversing heart disease. Interpersonal relationships were a surprising
discovery from his perspective. He pointedly states "I'm not aware of any other factor in
medicine - not diet, not smoking, not exercise, not stress, not genetics, not drugs, not surgery that has a greater impact on our quality of life, incidence of illness and the premature death from
all causes than does love and intimacy" (Omish, 1998 pg 2-3). To harmonize with Omish's
study, Stead (2005) concluded that group therapy allowed smokers to learn behavioral
techniques among their peers, with the intent of providing mutual support among group members
and it is nearly twice as efficacious as self-help programs (Stead, Lancaster, 2005).
Self-efficacy Theory

According to Bandura (1986), self-efficacy is the most important precondition for
behavior change. Self-efficacy is the belief that one has the power to produce an effect by
completing a given task or activity related to that competency. It also relates to a person's
perception of their ability to reach a goal, is the belief that one is capable of performing in a
certain manner to attain certain goals, and is based on the premise that it is an expectation that
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one can master a situation and produces a positive outcome. The three major factors that
influence self-efficacy are behaviors, environment, and personal and cognitive factors. They all
affect each other, but the cognitive factors according to Bandura are most important. Bandura
also postulates that motivation, performance, and feelings of frustration associated with repeated
failures will determine effect and behavior relations. (Bandura, 1986).
The three primary care sites of the Southeast Regional Health Departments serve the
uninsured where the providers encourage patients to master their specific situations to produce
positive outcomes. Smoking is rampant in these particular communities so empowering the
patients who have expressed a desire to quit their tobacco abuse is sanctioned and encouraged.
Practice Change Model
Rosswurm and Larrabee ( 1999) developed a change model which guides practitioners
through the full process of evidence-based practice (EBP). The model is based on theoretical and
research literature related to evidence-based practice, research utilization, standardized language,
and change theory. In this model, practitioners are guided through the entire process of
developing and integrating an evidence-based practice change. The model supports evidencebased practice changes derived from a combination of quantitative and qualitative data, clinical
expertise, and contextual evidence (Holleman, Eliens, van Vliet, & van Achterberg, 2006). It
includes six steps: assessing the need for change, identifying potential interventions and
outcomes, synthesizing the best evidence, designing a practice change, implementing and
evaluating the practice change, and integrating and maintaining the practice change.
(See Figure 1).
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Current Practice Protocol
The mission of the Tennessee Department of Health (TDH) is to protect, promote and
improve the health and prosperity of people in Tennessee. All 6.45 million Tennesseans, along
with those who visit our state, are touched directly or indirectly by TDH operations.
The current practice protocol regarding assessments of patients who smoke entails an
initial and annual smoking survey that is done by the primary care provider. The information is
then entered in a data base and later on evaluated by the Health Department's epidemiologist. In
the past year and a half, the project manager for this practice change proposal have seen patients
who have returned for their three month follow up and annual visits with essentially the same
answers. Unfortunately, the information gained becomes 'invisible' to the providers, but per the
current protocol, assessment of the patient's current smoking status should be asked with every
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encounter. Interventions presently integrated include referring the patients to other providers,
advising over-the-counter cessation medications, and prescribing pharmacologic agents such as
Bupropion and Varenicline. Provision of the Tennessee Quit Line information brochure which
encourages patients to call and will have the ability to speak with a 'quit coach' and learn how to
deal with tobacco cravings and other challenges is also distributed during an encounter.
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CHAPTER 2: LITERATURE REVIEW

Introduction
In recent years, there has been a proliferation of research studies on the effect of smoking
and the negative ramifications in terms of health and quality of patient outcome. The following
is a discussion and summary of evidence based literature reviews related to smoking cessation in
the primary care setting. The studies were done in the United States, Europe, Asia and Canada
and include quantitative and qualitative studies as well as meta-analyses spanning the years of
1995-2014. The project manager began the search using EBSCO, CINAHL, Pub Med, the
Cochrane Review and Health Sciences. The following key words and combinations were used:
Smoking Cessation in primary care, overview of smoking cessation in management in adults,
barriers to smoking cessation and relapse prevention.
On review of nursing research literature, the implementation of evidence-based tobacco
treatment guidelines into practice demonstrated that changes in the health care delivery system
and clinical workflow patterns can have an extensive effect on cessation rates. Due to the
plethora of available literature regarding smoking cessation, this literature review will pertain
only to the primary care setting.

Findings
Technology
The role of technology in improving systems approaches to tobacco treatment has been
recognized as a positive asset for primary care providers. Information obtained via technology
can reduce complexity and customize smoking cessation information through tailored cessation
education printed "on the fly" (Shiell, Hawe, & Gold, 2008). The recently enacted American
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Recovery and Reinvestment Act of 2009 calls for a $19 billion stimulus package to invest in
health information technology (Mandi & Kohane, 2009), including $17 .2 billion for financial
incentives to physicians and hospitals through Medicare and Medicaid to promote the use of
EHRs (Steinbrook, 2009). This investment represents an unprecedented opportunity to the
tobacco control research community to develop and test technologies to support evidence-based
tobacco treatment.
Ellerbeck, Ahluwalia, Jolicoeur, Gladden, & Mosier (2001 ), determined via an
observational study in the primary care setting that having an assigned smoking cessation nonphysician staff member actually increased the frequency of tobacco-related discussions during an
encounter, although this was not a significant smoking cessation predictor. In one particular
practice, an assigned nurse was designated to provide tobacco cessation intervention and followup utilizing technology, and smoking behaviors were addressed in 90% of all patient encounters
with smokers.
Despite the benefits of smoking cessation, clinicians are not adequately screening and
treating patients who smoke. One study, for example, found that only 50 % of smokers seeing a
primary care physician in the past year were asked about their smoking or urged to quit
(AnAnda, Remington, Sienko, Davis, 1987). An even smaller proportion was counseled to quit.
Some of the barriers to clinician intervention include time constraints, a perception that the
clinician lacks the skills necessary to be effective in this role, and low expectation of successfully
getting smokers to quit (JAMA, 1987).
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Smoking Cessation Guidelines
Practice guidelines calling for the treatment of all tobacco users have been released by
the Agency for Health Care Policy and Research (AHCPR) and the United States Preventive
Health Service. These were based on an exhaustive systematic review and analysis of the
scientific literature from 1975 to 1999, and were published in the year 2000 (JAMA 2000). The
American Psychiatric Association (APA) also released nearly identical guidelines (Am J
Psychiatry, 1996). Clinicians now have available a clearly defined standard of screening and
intervention to use with their patients.
The field of smoking cessation treatment itself also is rapidly expanding. Randomized
controlled trials of commonly used smoking cessation techniques, including individual, group,
and telephone counseling, have demonstrated success in helping smokers quit and maintaining
long-term abstinence (JAMA, 2000). In addition, rapid expansion in pharmacotherapy has
resulted in multiple drug agents and systems of delivery directed at treating the biologic basis of
tobacco addiction.
The AHCPR guidelines recommend that the tobacco use status of every patient treated in
a healthcare setting be assessed and documented at every visit (JAMA 2000). This practice has
been shown to increase the likelihood of smoking-related discussions between patients and
physicians and to increase smoking cessation rates, including smokeless tobacco, tobacco pipes
and cigar smoking (Okuyemi, Ahluwalia, Wadland, 2001).
Law, Tang, (1995), acknowledge the importance of specific advice to quit smoking,
regardless of the patient's motivational status, which should be underscored. Every patient who
smokes should be urged to quit in a clear, strong, and personalized manner. Not every patient
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counseled on smoking cessation will be prepared to consider quitting. Nevertheless, it is
important that the patient's smoking and motivational status be ascertained at each encounter. In
a systematic review of 20 studies conducted in primary care settings, brief (less than five
minutes) interventions that included advice to quit smoking resulted in two percent of all
smokers quitting, compared with less than one percent of those who received no advice.
A randomized trial found that informing patients of their "lung age" as determined by
spirometry (age of a healthy person with the same lung function) doubled quit rates at twelve
months (14 versus 6%) (Parkes, Greenhalgh, Griffin, Dent, 2008). The effect did not appear to
be altered by whether the lung age was normal or abnormal. There is little evidence that other
types of biomedical risk assessment increase smoking cessation rates compared to standard care
(Bize, Burnand, Mueller, et al. 2009).
The AHCPR has proposed the model of 5 Rs" in promoting motivation to quit smoking:
11

(Appendix 8).
•

Relevance -

Motivational information to a patient is more effective if it is relevant to a

patient's circumstances (such as prior quitting experience, disease status, or health concerns).
•

Risks -

The acute and long-term risks of smoking should be stressed. It is most effective

if smoking can be tied to the patient's current health or illnesses. For the healthy patient,
environmental risks, such as exposing spouses and children to smoking and thereby increasing
their risk of ill-health should be included. Smokers should also be made aware that children of
smokers are more likely to smoke.

PRACTICE CHANGE

Rewards -

33

Encourage the patient to identify potential benefits of smoking (such as

saving money, performing better in sports, improving the health of children and other
household members, etc).
Roadblocks -

Ask the patient to identify barriers or impediments to quitting and note

elements of treatment (problem solving, pharmacotherapy) that could address barriers.
Repetition -

Repeat the motivational intervention each time an unmotivated smoker

visits the clinic setting.

Barriers to Smoking Cessation
The concept of perceived barriers has been used in behavioral medicine for a long time in
one form or another. The earliest widespread use of the barriers concept was associated with the
Health Belief Model. Webster's dictionary defines a barrier as "something that impedes or
separates". Interestingly, the concept of barriers to accomplishment of a goal or a specified
health behavior is assumed to be so straightforward that it is often left undefined.
Gregory (2012), concluded that barriers to quitting smoking among the general
population include psychosocial factors such as anxiety, and depression as well as smoking
specific factors like motivation and self-efficacy to quit plus nicotine dependence. Of particular
notation, there was a difference in younger and older smokers in the study's sample. Older
smokers had a significantly lower level of nicotine dependence, stress, depressed mood, and a
greater prevalence of smoking-related diseases. Older smokers were more likely to achieve
biochemically verified abstinence at a 6-month follow-up than younger smokers (7 .8% vs 3.1 %
respectively). Having a smoking related disease did not however, influence quitting among older
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adults. For younger smokers, higher self-efficacy to quit and the presence of a smoking related
disease increased the odds of abstinence.
Kraemer et al. (2013) examined the role of emotional distress tolerance (DT) in
predicting barriers to smoking cessation and number of quit attempts. The sample consisted of
regular daily smokers (N= 126; 37 females; Mean age= 36.5 l , SD= 13.05) who completed selfreport measures on affect and smoking. The results indicated after controlling for daily smoking
rate and anxiety sensitivity, emotional DT significantly predicted internal barriers to cessation
(6.9% unique variance) but not external or addiction-related barriers to cessation. Inconsistent
with prediction, emotional DT did not significantly predict number of quit attempts. The authors
concluded that these results suggest that individuals who are low in emotional DT believe that
quitting smoking will be difficult because it takes away an important affect regulation strategy.
They additionally suggested there may be utility in targeting emotional DT in smoking cessation
interventions (Kraemer et al., 2013 ).
Fagan (2007) examined the relationship between smoking cessation counseling selfefficacy, knowledge of smoking cessation counseling, motivation to counsel smokers, and
barriers to performing smoking cessation counseling, relative to the smoking cessation
counseling stage of change. Healthcare providers (N=296) completed a survey measuring the
predictor variables of knowledge, motivation, self-efficacy and perceived barriers. The results
indicated that the healthcare providers were knowledgeable about smoking cessation counseling

and they had the self-efficacy to perform smoking cessation counseling effectively. The
physicians also reported three significant barriers to smoking cessation counseling. The first
listed was counseling time was not reimbursable by third party payers; secondly, smoking
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interventions were not their responsibility due to lack of training; third, lack of resources for
follow-up. There was a negative correlation between self-efficacy for smoking-cessation
counseling and barriers to performing smoking-cessation counseling. The authors concluded that
the study indicated that there was a moderate negative correlation between smoking cessation
counseling self-efficacy and perceived barriers to performing counseling. This fact indicated
that as self-efficacy increased, barriers decreased, specifying that environmental influences were
associated with the level of self-efficacy (Fagan 2007).
Carter-Pokras et al. (2011) studied and found that Latinos who smoke were less likely
than non-Latino white smokers to use pharmaceutical aids such as nicotine replacement therapies
or to receive physician advice to stop smoking. This qualitative study further explored barriers
and facilitators to smoking cessation among Latino adults in Maryland. Participants were
recruited through flyers, information sheets, and site visits at community health clinics and
Latino events, and were predominately of Central American origin. The study revealed barriers
and facilitators to smoking cessation among Latino adult tobacco users from both smokers' and
ex-smokers' perspectives. The authors concluded a notable finding which was social influence
(family, friends, or other social environment) played an important role in cessation among Latino
smokers, serving as both positive and negative factors of influence for the initiation and success
of quitting smoking. Favored by both current smokers and ex-smokers, lay health promoters
were effective agents to reach Latinos with smoking cessation interventions. In addition, the low
use of cessation services could have been improved by increasing awareness and availability of
Spanish-language cessation services (Carter-Pokras et al. 2011 ).
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The prevalence of tobacco use among urban African American persons aged 18 to 24
years not enrolled in college is alarmingly high and a challenge for smoking cessation initiatives
(Stillman, Bone, Avila-Tang, Smith, Yancey, Street, & Owings, 2007). The authors concluded
from data collected from inner-city neighborhoods in Baltimore, MD, that more than 60 percent
of young adults smoke cigarettes. Data from focus groups and surveys indicated that the sale and
acquisition of "loosies" (single cigarettes) were ubiquitous and normative and may have
contributed to the high usage and low cessation rates. This easy and affordable way to purchase
cigarettes from street vendors and stores undermines tax policies, promotes smoking as a
normative behavior, and may contribute to high smoking rates in some inner-city communities
(Stillman et al., 2007).
China has the largest number of smokers in any country in the world with a smoking
prevalence of 66% in adult men and 3% in adult women (Yang et al. 2005). Yet, only
a small proportion of current smokers ( 16%) have indicated an intention to quit (Yang et al.
2001). Lam, Jiang, Chan, & Chee, (2011) conducted a cross-sectional survey of hospital-based
healthcare professionals with direct patient contact. This was conducted in Guangzhou in 2006
with a self-administrated questionnaire to investigate their practice of smoking cessation
counselling, tobacco-related knowledge and attitudes, and perceived facilitators, barriers and
organizational support to cessation intervention practices. Significantly more female physicians
who were non-smokers (79.7%) reported "initiation and or advice" smoking cessation
interventions than male physicians who were smokers (71.2%) and non-smokers (71.6% ). The
findings highlighted the need for developing tailored smoking cessation training programs for
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physicians according to their smoking status and gender in China (Lam, Jiang, Chan, & Chee
2011).
Caplan, Stout, & Blumenthal, (2011) researched a tobacco cessation program among
African American physicians in private practice and healthcare providers at community health
centers in GA. Data collection to determine tobacco-control practice behaviors among
participating providers took place prior to training and at six months following training.
Identified were six barriers to providing smoking cessation services which included lack of time,
patient un-readiness to change, inadequate resources, language and culture barriers, patient noncompliance, and inadequate cessation clinical skills on the part of the providers. Of these six
barriers, the study's intervention addressed only two--inadequate cessation skills and inadequate
resources-but this was sufficient to result in significant behavior change on the part of the
participants. It was determined that the physicians' inadequate cessation skill was the most
important barrier. This was not surprising, since medical students generally do not receive
adequate training in approaches to smoking cessation. The study concluded that even though
smoking cessation counseling was provided by non-physician staff with good results, it is
likely that results will would be even better when it is a physician who provides-or at least
initiates-the smoking cessation intervention, since patients typically accord physicians the
most respect of any member of the health care team (Caplan, Stout, & Blumenthal, 2011).
In a another study, Akpanudo, Price, Jordan, K.huder, & Price, (2009) researched and
determined that the incidence of smoking among individuals suffering from various forms of
mental illness was inordinately high which was approximately 60% overall, compared to 25% in
the general population. The study also noted that clinical psychologists benefited from a number
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of potential advantages in offering smoking cessation counseling and treatment where they have
been specially trained in motivational techniques and have special expertise in helping patients
change their behaviors. A cross-sectional study of clinical psychologists' smoking cessation
practices and perceptions was the study's design. A random sample was surveyed regarding
their smoking cessation practices and perceptions (N= 352) utilizing the 5A's and 5R's. The
results indicated that counselors that had never smoked were almost two times more likely to
have higher efficacy expectations than those that were current smokers or ex-smokers (OR=
1.94, 95% CI 1.18- 3.12). The most frequently cited perceived barriers to providing smoking
cessation counseling were "not the patient's presenting problem," "I do not see this as a priority
for my client," and "may interfere with therapy goals." These findings portrayed that clinical
psychologists were more concerned that smoking cessation counseling may interfere or be
detrimental to the treatment of the primary mental health issue of the client even though studies
have demonstrated that concurrent treatment approach to both the presenting mental health issue
and tobacco use is feasible (Akpanudo, 2009).
Cessation in Primary Care
Law, Tang, (1995) acknowledges the importance of specific advice to quit smoking,
regardless of the patient's motivational status, which should be underscored. Every patient who
smokes should be urged to quit in a clear, strong, and personalized manner. Not every patient
counseled on smoking cessation will be prepared to consider quitting. Nevertheless, it is
important that the patient's smoking and motivational status be ascertained at each encounter. In
a systematic review of 20 studies conducted in primary care settings, brief (less than five
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minutes) interventions that included advice to quit smoking resulted in two percent of all
smokers quitting, compared with less than one percent of those who received no advice.
In a randomized controlled trial, Parkes (2008) examined the effect of smoking on quit
rate utilizing spirometry in the primary care setting. The objective was to evaluate the impact of
telling patients their estimated spirometric lung age as an incentive to quit smoking {N= 560) and
aged over 35 years. Independently verified quit rates at 12 months in the intervention and
control groups, respectively, were 13.6% and 6.4% (difference 7.2%, P=0.005, 95% confidence
interval 2.2% to 12.1 %; number needed to treat 14). People with worse spirometric lung age
were no more likely to have quit than those with normal lung age in either group. Cost per
successful quitter was estimated at 280 pounds sterling (366 euros, $556). A new diagnosis of
obstructive lung disease was made in 17% in the intervention group and 14% in the control
group; a total of 16% (89/561) of participants. The study concluded that telling smokers their
lung age significantly improves the likelihood of them quitting smoking, but the mechanism by
which this intervention achieves its effect was unclear.
A relatively new concept is that of "text messaging". Mobile phone text messaging
allows patients to receive personalized smoking cessation support through a series of automated
motivational messages. Messages suggest behavioral changes, provide positive feedback, and
allow patients to request additional assistance as needed. Randomized trials have found that text
messaging is effective for short- and long-term abstinence. In a meta-analysis including two
randomized trials of 1905 smokers, text messaging increased self-reported tobacco cessation at
four to six week follow-up, compared to control (RR 2.2, 95% CI 1.8-2. 7). Whittaker , Borland,
Bullen, et al, (2009). In a subsequent trial of 5800 smokers, those randomly assigned to text
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Group therapy allows smokers to learn behavioral techniques among their peers, with the
intent of providing mutual support among group members and it is nearly twice as efficacious as
self-help programs (Stead, Lancaster, 2005). One year quit rates for persons who complete such
programs are approximately 20 percent. Despite the efficacy of group therapy, only a minority of
smokers are willing to attend them, citing the inconvenience. Group sessions typically include
short didactic presentations about the quitting process, group interactions, exercises on selfmonitoring of one's smoking habit, some form of tapering method leading to a quit date,
development of coping skills, and suggestions among members for relapse prevention. Group
therapy allows patients to learn behavioral techniques from several participant perspectives while
mutually supporting others attempting to quit (Stead, Lancaster, 2005).
A noteworthy approach regarding smoking cessation in the primary care setting is that of
Problem Solving and Skills Training where the smoker anticipating quitting should be
encouraged to identify situations or activities that may increase the risk of smoking or relapse
(Ussher, 2005). Examples include having smokers within the household or at the workplace,
getting into stressful situations, and alcohol use. Once the "danger situations" have been
identified, coping skills should be explored. The nature and time course of withdrawal should be
described. Learning strategies (cognitive and behavioral) that will reduce negative moods may
also be helpful.
Strategies to enhance coping may include making lifestyle changes to reduce stress and
improve quality of life (eg, starting an exercise program, learning relaxation techniques). In one
randomized trial of 281 female smokers, vigorous exercise, used in conjunction with a cognitivebehavioral smoking cessation program, enhanced short and long-term (up to one year)
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abstinence, and delayed weight gain following smoking cessation (Marcus, Albrecht, King, et al.,
1999). Further investigation is required to clarify the potential role of exercise programs in
promoting smoking cessation.
The smoker should be encouraged by the practitioner to explore how to minimize the
time spent in the company of smokers. When other smokers are in the home, the recent exsmoker could consider negotiating with household members not to smoke within the home or
car. Lancaster T, Stead, (2002) concludes that the key to successful quitting is to equip the
smoker with as much information as possible about what to expect during quit attempts.
Supplementing information discussed during visits and on the telephone with self-help materials
may serve both as a reinforcer and a time saving resource for the clinician. These materials
include pamphlets or booklets and videos or audio tapes on smoking cessation, a hotline or help
line, the internet, and support groups. Several medical centers now have patient resources or
learning centers in which patients can access additional self-help materials (Lancaster, Stead,
2002).
A multidisciplinary approach has been researched and proven to be successful in the
primary care setting. Zwar, Richmond, Halcomb, et al., (2010) completed a study in recognition
of the chronic nature of tobacco dependence, where a multidisciplinary, team-based approach is
used, which has been implemented with successful abstinence rates in observational studies.
Utilizing other members of the care team, as well as making use of electronic systems to flag a
patient's active smoking status, more conversations between patients and clinicians may occur
during office visits as part of an overall strategy for a team approach to care. A study that looked
at the impact of adding smoking-related vital sign questions to patients' electronic records found
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that clinician-documented smoking cessation counseling rates were significantly increased
(McCullough, Fisher, Goldstein, et al., 2009). Other studies have looked at non-clinician-based
systems approaches to enhancing smoking cessation rates. For instance, one study found that
incorporating a smoking cessation template into electronic notes and providing patient education
during referrals to clinical pharmacists was an effective method to enhance smoking cessation
rates (Ragucci, Shrader, 2009).
Relapse after an attempt at smoking cessation is common. Most smokers make many
attempts to quit before they achieve success. The availability of over-the-counter smoking
cessation aides means that clinicians will see an increasing number of smokers who have already
made multiple unsuccessful attempts to quit. These patients may be highly dependent upon
nicotine, making it even more imperative that the clinician be knowledgeable about available
treatment options and resources. There is relatively little evidence that specific interventions
prevent relapse after smoking cessation, however, it is reasonable to try simple interventions that
promote abstinence (Hajek, Stead, West, et al., 2013). The clinician should take every
opportunity to encourage and congratulate the patient on quitting. The benefits of smoking
cessation can be highlighted by simply asking how their lives have changed since they stopped
smoking. An equally important step is to address any problems encountered as a result of
abstinence (e.g. weight gain, depression, or change in relationships with other smoking friends or
relatives). Fiore, Jaen, Baker, et al., (2008), studied and found that most smokers make many
attempts to quit before they achieve success. Smokers should be made aware of this when they
are attempting to quit, and when they have relapsed after a quit attempt. The clinician should
assess for non-adherence or improper use of cessation aides when a patient who has quit
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smoking relapses. Determining the patient's insight into the possible reasons why the attempt
failed and explore solutions for the next quit attempt would be an appropriate next step. Screen
and treat comorbid conditions that may affect relapse such as depression and also chemical
dependency other than nicotine. Referral was another approach for relapse prevention and
intervention to a subspecialty clinic or smoking cessation program for the smoker who is heavily
dependent upon nicotine or has had multiple unsuccessful attempts. Different types of providers
(physicians, nurses, psychologists, dentists) may improve smoking cessation rates; involving
multiple types of providers may enhance success. Intensive individual and group counseling also
is often effective (Fiore, Jaen, Baker, et al., 2008).
McCullough, Fisher, Goldstein, Kramer, Ripley-Moffitt (2009) studied strategies to
improve smoking cessation counseling in clinical settings which are critical to supporting
smokers' attempts to quit. This study evaluated the impact of adding two smoking-related vital
sign questions in an electronic medical records system on identification, assessment, and
counseling for patients who smoke: "Current smoker?" and "Plan to quit?" The method utilized
baseline data of no tobacco use assessment, and data after intervention (assessment of tobacco
use}, which were collected through record review of 899 randomly selected patient visits across
3 outpatient clinics. The results revealed from before to after intervention, identification of
smokers increased 18% (from 71 % to 84%; P<.001 ), and assessment for a plan to quit increased
100% (from 25.5% to 51 %; P<.005). Among all smokers, cessation counseling increased 26%
(from 23.6% to 29.8%; P=.41). Significantly more smokers who received the assessment for a
plan to quit received cessation counseling (46% vs. 14%, P<.00 l ). Regression analysis showed
that patients receiving an assessment for plan to quit were 80% more likely to receive cessation
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counseling (OR 0.209;95% CI, 0.095-0.456). The authors concluded that Physician-documented
counseling rates were significantly higher when patients are asked about smoking and assessed
for a plan to quit. Two questions that ask about smoking status and assess plans to quit may
provide prompts to increase the likelihood that patients who smoke receive cessation counseling
(McCullough, Fisher, Goldstein, Kramer, Ripley-Moffitt (2009).

Pharmacotherapy
Pharmacotherapy for smoking cessation aims to reduce the symptoms of nicotine
withdrawal, thereby making it easier for a smoker to stop the habitual use of cigarettes. The main
medications that have demonstrated efficacy as smoking cessation aids include nicotine
replacement, bupropion, and varenicline. Smoking cessation pharmacotherapy should be offered
to all smokers making a quit attempt, unless medically contraindicated (Fiore, Jaen, Baker, et al.,
2008). Since tobacco use is both a learned behavior and a physical addiction to nicotine for the
majority of smokers, the combination of counseling and pharmacologic therapies can produce
higher quit rates than either one alone (Rigotti, 2002). Smoking cessation clinical guidelines
from the United States Public Health Service consider seven drugs to be first-line agents for
tobacco cessation (Fiore, Jaen, Baker, et al., 2008). The Transdermal nicotine patch, Nicotine
gum, Nicotine lozenge, Nicotine inhaler, Nicotine nasal spray, Bupropion, and Varenicline are

the recommended guidelines and available in some countries are a nicotine mouth spray and
sublingual tablets.
The goal of nicotine replacement therapy (NRT) is to provide nicotine to a smoker
without using tobacco, thereby relieving nicotine withdrawal symptoms as the smoker breaks the
behavior of cigarette smoking. The use ofNRT in place of cigarettes avoids exposure to carbon
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monoxide that reduces oxygen delivery, to oxidant gases that are atherogenic, and to tars that are
carcinogenic.

Nicotine Replacement Products
Nicotine replacement products differ in their pharmacokinetics and delivery of nicotine to
the circulation (Rigotti, 2002). Nicotine is absorbed transdermally with the nicotine patch,
through the nasal mucosa by the nasal spray, or through the oral mucosa with the nicotine
chewing gum, mouth spray, lozenge, sublingual tablet, or inhaler. No product delivers nicotine as
rapidly as cigarette smoking, a factor that contributes specifically to the dependence-producing
properties of cigarettes. The patch has a long-acting, slow-onset pattern of nicotine delivery,
producing relatively constant withdrawal relief over 24 hours, but requiring several hours to
reach peak levels. Compliance with the patch is high, but the user has no control of nicotine dose
to respond to nicotine cravings and withdrawal symptoms during the day. By contrast, the nasal
spray and oral forms of nicotine replacement (gum, lozenge, and inhaler) share a short-acting but
rapid-onset pattern of nicotine delivery that allows the user flexibility to respond to acute
cravings or withdrawal symptoms. However, the nasal and oral forms require repeated use
throughout the day, lead to more variable nicotine levels, and require more instruction for correct
use. Currently, there are three NRT products which are available in the US without a prescription
(patch, lozenge, and gum). Two (nasal spray and oral inhaler) are available by prescription only.

Electronic cigarettes
Electronic cigarettes ( e-cigarettes) use an electronic delivery system that aerosolizes
nicotine. Many e-cigarette products are available that vary in their consistency and nicotine
delivery. Several have been studied for smoking cessation, but data supporting their efficacy in
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this context are lacking. Electronic cigarettes (e-cigarettes) use an electronic delivery system
that aerosolizes nicotine, producing a vapor similar to cigarettes but containing fewer traditional
toxins (Yamin, Bitton, 2010). E-cigarette devices are composed of three parts: a plastic tube, an
electronic heating element, and a liquid nicotine cartridge. The user presses a button that
simultaneously releases a puff of vaporized nicotine while illuminating the device tip (that
simulates the lit end of a cigarette). E-cigarettes do reduce the desire to smoke traditional
cigarettes and have been prescribed by clinicians to aid in smoking cessation (Bullen C,
McRobbie, Thomley, et al., 2010).
E-cigarettes are being increasingly used by the general population, mostly as a result of
internet advertising and sales (Etter, 2010). There are many available products that vary greatly
in consistency, in nicotine delivery, and in other additives that may have their own toxicity. A
2009 US Food and Drug Administration (FDA) report one-cigarettes found trace amounts of the
harmful solvent diethylene glycol as well as nitrosamines which are known carcinogens. This
report also found nicotine in 'light' e-cigarettes that were labeled as being nicotine-free. The
FDA has not approved the use of any e-cigarettes given safety concerns, particularly related to
use in adolescents and potential toxic ingestion among children
(fda.gov /Safety/MedWatch/Safetylnformation/SafetyAlertsforHumanMedicalProducts/ucm 1733
27.htm). Data from one pilot study reports common adverse effects of e-cigarettes as dry cough
and irritation in the oropharynx (Polosa, Caponnetto, Morjaria,, et al., 2011 ). Whether initial
recreational use of e-cigarettes leads to smoking of conventional cigarettes is unknown.
Despite their increasing popularity, little is known about e-cigarette use, potential for
addiction, or long-term health effects from smoking and second-hand smoke. Whether e-
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cigarettes can help smokers to quit or permanently stop using tobacco products is uncertain
(fda.gov/Safety/MedWatch/Safetylnformation/SafetyAlertsforHumanMedicalProducts/ucm 173 3
27 2010). A randomized trial that compared e-cigarettes with nicotine patches among smokers
who wanted to quit found no significant difference in the cessation rates produced by the two
treatment arms, although the study was underpowered and could have missed important
differences in the effectiveness of e-cigarettes compared with patches (Bullen, Howe, Laugesen,
et al.(2013). While this trial suggests that e-cigarettes might have the potential to be smoking
cessation aids, further studies will be required to establish the efficacy and safety of e-cigarettes
for cessation.

Relapse Prevention
Most relapses occur soon after a person quits smoking, yet some people relapse months
or even years after the quit date. All clinicians should work to prevent relapse. Relapse
prevention programs can take the form of either minimal (brief) or more intensive programs.
There is relatively little evidence that specific interventions prevent relapse after smoking
cessation (Hajek, Stead, West, et al., 2013), however, it is reasonable to try simple interventions
that promote abstinence. The authors conducted randomized or quasi-randomized controlled
trials of relapse prevention interventions with a minimum follow-up of six months. They
included smokers who quit on their own, were undergoing enforced abstinence, or were
participating in treatment programs. They included trials that compared relapse prevention
interventions with a no intervention control, or compared a cessation programs with additional
relapse prevention components with a cessation programs alone.
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The clinician should take every opportunity to encourage and congratulate the patient on
quitting. The benefits of smoking cessation can be highlighted by simply asking how their lives
have changed since they stopped smoking. An equally important step is to address any problems
encountered as a result of abstinence (eg, weight gain, depression, or change in relationships
with other smoking friends or relatives). Relapse prevention should be part of every encounter
with a patient who has quit recently. (Hajek, Stead, West, et al., 2013). Most smokers make
many attempts to quit before they achieve success. Smokers should be made aware of this when
they are attempting to quit, and when they have relapsed after a quit attempt. The clinician
should assess for non-adherence or improper use of cessation aides when a patient who has quit
smoking relapses. Determine the patient's insight into the possible reasons why the attempt failed
and explore solutions for the next quit attempt. Screen and treat comorbid conditions that may
affect relapse such as depression and/or chemical dependency other than nicotine (Hajek, Stead,
West, et al., 2013).
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CHAPTER 3 - PROJECT DESCRIPTION
Introduction

The primary care setting is an ideal location for the promotion of smoking cessation
through counseling and pharmacological interventions. Smoking cessation options should be
offered by PCPs at each office visit. Meta-analyses of clinical trials have found that behavioral
counseling and pharmacotherapy with nicotine replacement each has strong evidence of efficacy
for smoking cessation, and that the combination of the two methods produces the best results
(Stead, Lancaster, 2012). The United States Public Health Service clinical practice guide
"Treating Tobacco Use and Dependence: 2008 Update" states that all health professionals need
to more effectively engage all patients who smoke (Fiore, et al., 2008). This information is of
importance due to a study of 1,898 patients who reported that they had been asked about tobacco
use or were advised to quit during their latest visit had a 10% greater satisfaction rating and 5%
less dissatisfaction than those who did not report such discussions (Fiore, et al., 2008).
Telephone QuitLine counseling has been effective in the past with diverse populations
and has had a broad reach. Therefore, both clinicians and health care delivery systems should
continue to ensure patient access to QuitLines and promote QuitLine use. Recent studies, (figure
B), however have shown that the Tennessee QuitLine calls has been on the decline and from a
personal perspective, a large percentage of patients have not called or gained advice to quit
tobacco after getting a QuitLine card or brochure.
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McCullough, et al., (2009) studied strategies to improve smoking cessation counseling in
clinical settings which are critical to supporting smokers' attempts to quit. This study evaluated
the impact of adding two smoking-related vital sign questions in an electronic medical records
system on identification, assessment, and counseling for patients who smoke: "Current smoker?"
and "Plan to quit?"(McCullough, et al., 2009).
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Practice Change
The goal of the practice change is to provide improved patient care by increasing providers'
adherence to the recommendations of a clinical practice guideline for the assessment and
treatment of smoking cessation in the primary care setting.
Rosswurm and Larrabee's model proposed that six phases are involved in a practice change.

•

Assessing the need for a practice change. The Southeast Regional Health Departments
currently does a smoking assessment survey on new and annual patients. The data
collected unfortunately becomes 'invisible' to the practitioners in terms of patients'
desire to quit or their history of smoking cessation attempts. This information is based
solely on observation for approximately one year by the project leader. Formal data
collection or research has not been done to validate the findings however, clinical
experience has given reasonable support for the need for this practice change. The
QuitLine is also used as an intervention where brochures and cards are provided to the
patients, but on return visits based on the project leader's observation, the QuitLine
approach has not proven to be an effective intervention. Patients have expressed that
they "just don't call", "don't want to call back" after the initial attempt, or they are "not
motivated to call". An official primary meeting is generally held quarterly and an
assessment of the current practice of addressing smoking cessation among the providers
would be discussed and identification of current and experienced problems would be
discussed.

•

Linking the problem with nursing interventions and patient care outcomes. According to
the recent tobacco use update guidelines (Fiore, 2008), increasing evidence has shown
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that screening and assessment practices such as expanding vital signs to include tobaccouse status, or other reminder systems to ask about smoking significantly increases the rate
of clinician intervention. Presently, the three primary care sites do not include patient's
tobacco use status on the progress notes as a component of the vital signs.
For smokers who are not ready to quit, the clinician's role is to assess the patient's
perspective (of the risks and benefits of continuing to smoke) in order to help the smoker
to begin to think about quitting. Most smokers have a general desire to stop smoking, but
may not be ready to take specific action to quit, for a variety of reasons. Asking a smoker
what he or she likes and does not like about smoking is a way to start. A personalized
message concerning a smoking-related health problem may motivate some patients into
action. Clinicians can use motivational interviewing techniques to explore a smoker's
feelings, beliefs, ideas, and values regarding tobacco use. The model of "5 Rs"
(Relevance, Risks, Rewards, Roadblocks, Repetition) is helpful to motivate smokers who
are not ready to quit (Appendix B).
•

Synthesizing the best evidence. Based on current research, providers should note that
simply giving standardized self-help materials (QuitLine) to a patient may have little
positive effect on his or her success. Every smoker should be asked if he or she is willing
to quit. If the patient wants to attempt to quit, the clinician should guide the patient in
selecting an appropriate treatment. It is important to understand the stages of motivation
utilizing the TIM, to change behavior in order to plan an effective intervention. Most
smokers (80%) fall into one of two of the change categories: pre-contemplation or
contemplation. The two distinct groups of individuals need very different approaches to
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smoking cessation. Patients who fall into the pre-contemplation stage are not convinced
the health hazards associated with smoking apply directly to them. They may not want to
make a change in smoking as a health behavior, or they may express doubts about their
ability to successfully make a change. The goal for these patients are to instill a sense of
doubt about the desire to continue smoking, raise an awareness of the health hazards of
smoking and their direct effect on the patient's health and well-being and communicate
the benefits of quitting, exploring the positive perceptions the patient has about smoking
may help overcome the resistance commonly seen in this stage of the change process.
Patients in the contemplation stage seek out information about the quit attempt but are
unwilling to make a commitment to quit or express self-doubt about their ability to
successfully quit. Identifying the positive and negative aspects of continuing to smoke
and emphasizing the negative consequences of continuing to smoke will help the
contemplator resolve ambivalence toward continuing to smoke.
The use of an algorithm has proven to be an effective tool which integrates the
recommendations of the major guidelines and meta-analyses and provides rationales for
its treatment decisions. An algorithm suggests a brief assessment followed by use of one
to two medications and counseling in most smokers. Because all treatments appear
equally effective and have few adverse events, the algorithm suggests clinicians inform
smokers of the pros and cons of the different treatments, and recommend use of one or
more of each (Bader, McDonald, Selby. 2009). The proposition of having an algorithm
for providers to employ during encounters will also be an entity of the proposal for the
practice change at the primary care sites.
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Designing the practice change. Based on peer reviewed, current evidence based
literature, the proposal would entail three entities to supplement, enhance and intensify
the already established protocol. The first would be to incorporate the TTM on stages of
change and respond appropriately based on their motivation. An added section with the
five stages of change from the TTM would be on the progress notes to be addressed with
each encounter. Patients would continue to be provided with the Tennessee Quit-line
information. The second would be to include the patients' smoking status as a part of the
'vital sign' section which could be determined by the certified nurse's assistances
(CAN's). The third proposition would be to have an algorithm as a guide for the
necessary approaches for smoking cessation in the primary care setting. This proposal
would then be given to the regional medical director to review and then present same to
the regional director for the Southeast Region of Health Department for review by the
board of directors.

•

Implement and evaluate change in practice. This practice change project would involve
interacting with the Tennessee Department of Health (TDH) patients, their surveys, and
chart reviews at the local health departments. The requirements would entail an
application to the TDH IRB which would need a review prior to submission to the TDH
IRB by the Regional Director and the Medical Director of Community Health Services.
A development of a two page executive summary of the project with the research query,
methods, eligible population that would be researched and why, data analysis plan, and
the potential conclusions and knowledge that will be gained by the project. After
approval of the overall plan, then a pilot study would be done for approximately six
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months while evaluating the process and outcomes. A decision would then be
determined to adapt, adopt or reject the practice change.

•

Integrating and maintaining the change in practice. Upon acceptance of the proposal, a
pilot study would be in order for approximately six months to one year to determine the
efficacy of the proposed change and on the annual evaluations of the smoking cessation
surveys by the epidemiologist, determining statistical significance would be deemed
positive or negative. Communicating the results and the recommended change of the
pilot study at the quarterly primary care meeting would be done to ensure appropriate
integration into the standards of practice.

Proposal
When providers sees a patient for the first they should first assess the patient's tobacco
use, the desire to stop smoking, and the history of previous quit attempts, including methods used
and their effectiveness (West, 2004). A smoker's dependence on nicotine can be estimated from
the duration of smoking history, the number of cigarettes smoked daily, and how soon after
waking up the smoker has his or her first morning cigarette. More dependent smokers have
smoked for many years, smoke more cigarettes daily, and smoke within the first 30 minutes of
awakening. The smoker's degree of nicotine dependence predicts the difficulty that he or she will
have in quitting and the intensity of treatment likely to be required (West, 2004).
Two strategies studied to improve smoking cessation counseling in the clinical setting
involves the inclusion of smoking related vital sign questions inquiring of the current tobacco
usage and determining the current stage of change. McCullough, et al., (2009), concluded that
this approach proved to be beneficial (Appendix F).

PRACTICE CHANGE

57

The use of an algorithm in the primary care setting has proven to be beneficial by
providing a step-by-step procedure for health care practitioners to initiate a smoking cessation
protocol into practice. It also serves as a concise, evidence-based resource that can be used by
providers during a visit in a timely manner (Jones, 2014). After gaining consent from the
publishers from two articles, an algorithm was developed after adapting, and pertained directly to
the population at the Southeast Region Health Departments (Appendix D-a, Appendix D-b).
Cost is an important financial concern to the Southeast Region Health Departments and
the selection of projects that may contribute most to the attainment of its objectives, given
resource constraints, is crucial and fundamental. The three proposed components may be a cost
benefit in the future. The projected cost on acceptance of this proposal may entail obtaining
additional resources from the CDC's publication department regarding handouts or brochures for
encouraging and maintaining smoking cessation in addition to the already established QuitLine.
The algorithm suggests distributing patient centered information depending on the stage of
change they are currently experiencing. UpToDate® (UTD) is an already established and
consumed computer access to the providers which synthesizes the most recent medical
information into evidence-based practical recommendations clinicians trust to make the right
point-of-care decisions. With appropriate terminology in the search engine, UTD offers two
types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient
education pieces are written in plain language, at the 5th t<;> 6th grade reading level, and they
answer the four or five key questions a patient might have about a given condition. These articles
are best for patients who want a general overview and who prefer short, easy-to-read materials.
Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed.
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These articles are written at the 10th to 12th grade reading level and are best for patients who
want in-depth information and are comfortable with some medical jargon.
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CHAPTER FOUR: EVALUATION PROCESS
Introduction to the Evaluation Process

On approval of acceptance of the proposal, a six month pilot study of the two additional
components of the vital signs and the addition of the TTM's stages of change will be utilized by
the six primary care providers in the various counties of East Tennessee. An evaluation survey
of the positive or negative effects of the proposed algorithm will then be distributed to each of
the providers for a discussion at the following primary care meeting at the Southeast Regional
Office in Chattanooga, Tennessee.
CDC Framework for Program Evaluation

The Centers for Disease Control and Prevention (CDC) Framework for Program
Evaluation in Public Health provides guidance and structure to aid in the development of a
comprehensive evaluation design that meets the evaluation standards set by the Joint Committee
on Standards for Educational Evaluation and ensures the evaluation produces relevant, useful
information (Centers for Disease Control and Prevention, 1999; Joint Committee on Standards
for Educational Evaluation, 2010). The framework consists of six steps: (a) engaging
stakeholders, (b) describing the program, (c) focusing the evaluation design, (d) gathering
credible evidence (e) justifying the conclusions, and (t) ensuring utilization and sharing lessons
learned (Figure 3).
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Figure 3. The CDC Program Evaluation Framework

cdc.gov/eval/framework/index.htm

The steps are essential, interdependent, and iterative, but allow the flexibility to tailor an
evaluation based on the program's context and the purpose of the evaluation. The underlying
logic of the Evaluation Framework is that good evaluation does not merely gather accurate
evidence and draw valid conclusions, but produces results that are used to make a difference.

Step 1: Stakeholder Engagement
Program evaluation is one of ten essential public health services and a critical
organizational practice in public health. According to CDC (2011 ), the first step in this process
is engaging stakeholders. Stakeholders are people or organizations invested in the program and
interested in the results of the evaluation. Representing their needs and interests throughout the
process is fundamental to good program evaluation. The participation of stakeholders ensures
their perspectives and values are understood, and increases buy-in to the findings and changes
made as part of the process (Centers for Disease Control and Prevention, 1999; Minkler, 2005;
Patton, 2008).
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The evaluation process will include several stakeholders of the Southeast Regional
Health Departments including, but not limited to the Regional Director, Medical Director of
Community Health Services, Director of Quality Improvement, epidemiologist, providers, staff,
and patients as active participants, with each participant providing input from their unique
knowledge and experiences. Program evaluation involvement can be empowering and allow
each voice to be heard however, it may require a commitment of time and effort that may be hard
for some individuals and not feasible for others within the time constraints of the proposal.
Patients input will be particularly important because their needs, attitudes, and goals may differ
significantly from individuals from the other stakeholders and their perspectives may differ from
the health care providers. Stakeholder involvement would be maintained throughout the entire
practice change protocol evaluation process.
Step 2: Program Description
The second step of the CDC framework is an accurate, comprehensive description of the
program. A comprehensive program description clarifies all the components and intended
outcomes of the program, thus helping the project manager focus the evaluation on the most
central and important questions.
A comprehensive program description includes the following components:
Need. The public health problem that will be addressed with this practice change is the
seemingly lack of smoking cessation among the primary care patients in the Southeast Regional
Health Department ages 19-64 years in the past 18 months.
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Targets. To ensure progress with this public health problem, the attention of the Office of

Quality Improvement and the Medical Director of Community Health Services needs to be
aroused.
Outcomes. The ultimate outcome would be a significant reduction of tobacco use by

incorporating the proposed additional vital signs, the algorithm, and the distribution of pertinent
brochures based on the patient's stage of change. Currently, only one intervention, QuitLine
brochures, is distributed to the patients with limited information to address TTM stages of
change.
Activities. During the work up of patients, CNA's will be able to ask questions pertaining to

tobacco use and determine their stage of change. The provider will assess their smoking status
and will then distribute the appropriate handout or recommend medications for patients willing
to quit or reduce their tobacco usage.
Outputs. The tangible capacities that will be produced by this program's activities would be

attaining the ultimate goal of the Tennessee Department of Health Mission: To protect, promote,
and improve the health and prosperity of people in Tennessee.
Resources and Inputs. In order for these activities to be mounted successfully would include

brief training of the CNA's during the assessment of vital signs, informing the other primary care
sites and their providers of the change to the progress notes, sharing the concise algorithm and
various treatments for medication use. Regarding cost, these three components of the proposal
would eventually prove to be perhaps a cost benefit in terms of a decrease in tobacco usage and
consequently a reduction in tobacco related illnesses and diseases due to the easy accessibility to
the providers. The projected miniscule cost on acceptance of this proposal may entail obtaining
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additional resources from the CDC's publication department regarding handouts or brochures for
encouraging and maintaining smoking cessation in addition to the QuitLine. Regarding
documentation forms, a master copy is located on the hard drive which is easily amended by the
appropriate staff which are generally printed weekly on an as needed basis.
Stage of Development. This program is in its planning stage. After approval of the program by
the appropriate committee, then it would progress to the implementation stage.
Context. The factors and trends in the larger environment which may influence this program's
success or failure include lack of patient's motivation to quit tobacco use, providers negligence
of addressing tobacco usage at each office visit, and close involvement of the Medical Director.
Step 3: Focus the Evaluation Design
According to CDC (2011 }, the design is to be determined by the purpose and aims of
evaluation, the intended uses of the findings by the key stakeholders or decision- makers in a
program, and resources available to conduct the evaluation. The design for this proposal for a
practice change would look retrospectively at the quit rate prior and the quit rate after
implementation of the change. After obtaining IRB approval and completing the necessary
required documents, access to the electronic data base and review of charts for the past 18
months would be compared to at least six months' worth of implementation of the proposal for
the practice change.
Step 4: Gather Credible Evidence
Evidence gathering in a program evaluation is analogous to data collection in research
studies. The data gathered must be credible and relevant for answering the evaluation questions.
The use of mixed methods of data collection with qualitative and quantitative data is
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recommended to increase the richness and accuracy of the data (Johnson & Onwuegbuzie, 2004;
malterud, 200 l ). Data sources are determined by the research query and may include client
records individual interviews of participants, staff, and key informants, program policies and
procedure manuals.
The recommended combination of qualitative and quantitative data will be used in the
evaluation of the proposal for smoking cessation in the practice change.

Step 5: Conclusions
This step encompasses analyzing the evidence, making claims about the program based
on the analysis, and justifying the claims by comparing the evidence against stakeholders'
values. In the CDC program evaluation framework, conclusions are justified through synthesis
of the findings obtained from data analysis interpreted within the conceptual framework and
context of the program, and the values of the stakeholders (Baker, Davis, Gallerani, Sanchez, &
Viadro, 2000).
This interpretation and judgment concerning the practice change will be performed in
collaboration with the key stakeholders. The data analysis results will be presented at the
quarterly primary care meetings with the Medical Director, the primary care providers, the
registered nurses and some ancillary staff.

Step 6: Evaluation Use and Dissemination
The final step in the CDC program evaluation framework is to ensure use of the
evaluation findings and lessons learned. To accomplish this step, plans should be made at the
very beginning of the program evaluation process. The design must be tailored to achieve the
uses intended by the primary stakeholders. The evaluation findings must be credible and any
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recommendations made must be feasible to increase the likelihood of their use. The primary
uses of the proposal evaluation information will be the Regional Medical Director and the
Medical Director of Community Health Services. As directors within public health system, these
individuals will anticipate that the program evaluation results would reveal areas of strength and
weaknesses in the program and provide insight into the clients' experiences. This information
will provide insight into needed refinements and methods of improving the program. Active
participation of these stakeholders in the program evaluation process will perhaps increase the
likelihood that they will accept and use the findings. Feedback to and from the users at each step
of the evaluation process by email and periodic meetings will maintain involvement and ensure
the evaluation continue to be focused, relevant, and useful (CDC, 2005).
The ultimate purpose of a program evaluation is to use the information to improve
specific programs. The purpose initially identified early in the evaluation process should guide
the use of the evaluation results. The evaluation results can be used to demonstrate the
effectiveness of the program, identify ways to improve the current program, modify program
planning, and demonstrate accountability. Dissemination involves communicating evaluation
procedures or lessons learned to relevant audiences in a timely, unbiased, and consistent manner.
Regardless of how communications are structured, the goal for dissemination is to achieve full
disclosure and impartial reporting (CDC, 2011).
Evaluation Method

The evaluation method proposed for this practice change would consist of both
qualitative and quantitative methods. Identifying how many cigarettes are smoked and how
often, daily or weekly, would satisfy the quantitative method. Identifying the positive use of the
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information provided and what it meant from the patient's perspective would satisfy the
qualitative method. Quite often qualitative data can provide contextual meaning to the
quantitative data in a project that uses both (Zaccagnini, & White, 2011 ). Tools that may
possibly be utilized would include interviews, written questions and surveys, health factors, and
chart reviews.
According to CDC (2011 }, a logic model is a systematic and visual way to present the
perceived relationships among the resources one has to operate the program, the activities ones
plans to do, and the changes or results one hopes to achieve. It is a picture of how the project
developer believes the program will work and uses a series of diagrams to indicate how parts of
the program are linked together or sequenced. The logic model depicted in Figure 4, clearly
summarizes all the entities specific for this practice change proposal.
Inputs - These are materials that the organization or program takes in and then processes
to produce the results desired by the program.
Activities These are used by the program to manipulate and arrange items to produce
the results desired by the program.
Outputs Outputs are usually the tangible results of the major processes in the
organization. They are usually accounted for by their number, and in this example, the
number of calls to the QuitLine or use of prescribed medication.
Outcomes -These are the results of the impacts on those people who may have benefitted
from this program. Outcomes are usually specified in terms of: a) learning, including
enhancements to knowledge, understanding, perceptions, attitudes, and behaviors
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Promoting Smoking Cessation Among Young People and Adults
Logic model for promoting smoking cessation among young people and adults

£......... al

amlJon ....... ill

. _ . , . Klaal*.

---~

.......................
Figure 4: Logic Model
http://www.cdc.gov/tobacco/tobacco control programs/surveillance evaluation/evaluation manual/pdfs/
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Data Analysis

Content analysis will be used to analyze the qualitative data obtained from interviews,
focus groups, and comments written on participant surveys. The content analysis would be
determined by the specific concerns for the practice change, using a simple, systematic,
verifiable process. Each interview, focus group discussion, and participant survey comment will
be transcribed and each line numbered. Possible descriptive statistics of the data may include
frequencies, means and summary statistics. To identify any significant changes in the tobacco
survey and patients' smoking cessation status, possible pre and post intervention measures would
be analyzed with the paired t test. The level of significance for each analysis would be
designated as less than 0.05. Data would be analyzed by using the Statistical Package for Social
Sciences (SPSS) Graduate Pack 22.0, student version with the assistance of the epidemiologist
and a statistician.
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CHAPTER 5: RECOMMENDATIONS
The primary care setting is the ultimate location to promote smoking cessation through
counseling and pharmacological aids. Effective smoking cessation options should be promoted
by primary care providers at every opportunity and may be reimbursed through private and
public health care programs for smoking cessation counseling during a regular office visit.
Assessing tobacco use status during healthcare visits increases the likelihood of smokingrelated discussions between patients and clinicians, as well as increases smoking cessation rates.
The clinician should assess the patient's cigarette use, the desire to stop smoking, and the history
of previous attempts to quit, including methods used and their effectiveness. The importance of
specific advice to quit smoking, regardless of the patient's motivational status, should be
underscored. Every patient who smokes should be urged to quit in a clear, strong, and
personalized manner. Not every patient counseled on smoking cessation will be prepared to
consider quitting.
For smokers who are not ready to quit, the clinician's role is to assess the patient's
perspective of the risks and benefits of continuing to smoke, in order to help the smoker to begin
to think about quitting. Clinicians should also use motivational interviewing techniques to
explore a smoker's feelings, beliefs, ideas, and values regarding tobacco use. The USPHS
guideline has proposed the model of "5 Rs" (Relevance, Risks, Rewards, Roadblocks,
Repetition) in promoting motivation in patients who are unwilling to quit.
The hope and goal of this practice change protocol was to provide improved patient care
by increasing providers' adherence to the recommendations of a clinical practice guideline for
the assessment and treatment of smoking cessation in the primary care setting. The project
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manager has determined that there is sufficient evidence to warrant initiating the process of a
practice change. Internal data, though available to TDH staff only, has evidenced the need for a
change regarding the assessment and implementation for smoking cessation achievement. A
major barrier that was encountered for this practice change implementation was initiating the
IRB process, which was quite involved, and required a minimum of twelve weeks before a
review by the IRB committee (Appendix H). The field of smoking cessation treatment is rapidly
expanding. Randomized controlled trials of commonly used smoking cessation techniques,
including individual, group, and telephone counseling, have demonstrated success in helping
smokers quit and maintaining long-term abstinence. In addition, rapid expansion in
pharmacotherapy has resulted in multiple drug agents and systems of delivery directed at treating
the biologic basis of tobacco addiction. The project manager and the medical director discussed
at length the possibility of presenting the above mentioned protocol with extensive evidence
based literature to confirm the need of a change.
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Appendix - A Tobacco Survey
Patient Tobacco Survey
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Appendix B
F"sve "R's" to motivate smokers unwiling to quit

Intervention

Technique

Relevance

Encourage the patient to indicate why quitting is personally relevant, being as specific
as possible. Motivational information has the greatest impact if it is relevant to a
patient's disease status or risk, family or social situation Ceo. having children in the
home), health concerns, age, gender, and other important patient characteristics Ceo.
prior quitting experience, personal barriers to cessation).

Risks

Ask the patient to identify potential negative consequences of tobacco use. The clinician
may suggest and highlight those that seem most relevant to the patient. The clinician
should emphasize that smoking low-tar/IOw-nicotine cigarettes or use of other forms of
tobacco (eg, smokeless tobacco, cigars, and pipes) wiH not eliminate these risks.
Examples of risks are:
Acute risks - Shortness of breath, exacerbation of asthma, harm to pregnancy, impotence,
infertility, and increased serum carbon monoxide.

Long-term risks - Heart attacks and strokes, lung and other cancers (larynx, oral cavity,
pharynx, esophagus, pancreas, bladder, cervix), chronic obstrudive pulmonary diseases
(chronic bronchitis and emphysema), long-term disability, and need for extended care.
Environmental risks - Increased risk of lung cancer and heart disease in spouses; higher rates

of smoking in children of tobacco users; increased risk for low birth weight, Sudden Infant

Death Syndrome, asthma, middle ear disease, and respiratory infections in children of
smokers.
Rewards

Ask the patient to identify potential benefits of stopping tobacco use. The dinician may
suggest and high~ohtthose that seem most relevant to the patient.

I
I

Examples of rewards include:
Improved health
Food will taste better

I

lmpn>ved sense of smell
Save money

I
I
I
I

Roadblocks

Feel better about yourself
Home, car, ctothing, breath will smell better

can stop worrying about Quitting

II

Set a good example for and have healthier babies and children

Not worry about exposing others to smoke
Feel better physically and perform better 1n physical activities
Reduced wrinkling/aging of skin

Ask the patient to identify barriers or impediments to quitting and note elements of
treatment (problemsolving, pharmacotherapy) that could address barriers.

Typical barriers might include:

I

Withdrawal symptoms
Fear of failure

I
I

Repetition

Weight gain

Lack of support
Depression
Enjoyment of tobacco

The motivational intervention should be repeated every time an unmotivated patient
visits the clinic setting. Tobacco users who have faded in previous quit attempts should
be told that most people make repeated quit attempts before they are successful.

,.,c, Jaen C, Bilker T, et al. Treating tobacco use and dependence: 2008 update. Clinical
Practice Guideline. Rockville, ,.,D: US Department of Health and Human Services. Public Healt:h Service. 2008.

Adapted from: Fiore
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Appendix C
Five "A's" for assessing for tobacco use and addressing smoking cessation
Intervention

Technique

Ask

~tan

officewide system that enSlles that, for every patient at every enc visit, tobacco-use status IS ~dand doclll1ellted. Repeated assessment is not
necessaiy in the case of the arult who has never used tobacco or has not used tobacco for ~yyears, and fur whom tllis infurmation IS clearly doclll1ellted in the medical
record.

Advise

Strorefl ll'ge all tobacco users to quit in a clea.-, strong, personaized manner.
Advice shoUd be:
Clear • 'I tlri t is ~foryoo to QI.it smoblg now and I can ~you. 'Ct.ttilo down whie yoo are ii 1s not ~·
strong • ·As yru clrician, Ineed yoo to know that~smob1g IS the most ~
thin9 yoo can do to proted YOU' health now and in tile h.tll'e. The dilic staff and I w•
~you.

P~naized•fie tobacco use to C\ll'ent health/hss, arwl/or its soda and economic costs, motivation level/readness to QI.it, arwl/or the inpad of tobacco use on ~enand
others in the household

Assess

att•

Determinie the patienrs w~to ~t smoblg within the next 30 days:
If tile patielt is wililg to make a QI.it

at tlis tine, provide assistance.

att•

If tile patient wil p~atein an intensive treatment. deliver such a treatment or refer to an intensive intervention.

If tile patient dearly states he or she is 111wl1'1Q to make a QI.it

at this tine, prolide a motivational intervention.

If the patient is a meiOOer of a special population (eo, adolescent, preonart smoker), prolide ad<itional irtormation speclic to tllat population.

Assist

Provide aid for the patient to ~t. These actions a.-e sunmarized in the acc~nying table.

Arrange

Sched.ie folow·14> contact, either in pe!50fl or by telephone. Folow·14> contact shoUd occlJ' soon after the ~t date, preferably dtlilg the first week. Asecond folow·14>
contact is recommended within the first montll. Sc~liJther folow·14> contacts as in<icated.
C~b.iate success

dtlilg each folow-141. If tobacco use has occlfTed, review ci'C1111Stances and elicit reconrnitrnent to total abstilence. Remind the patient that a lapse
can be used as a leanWig experience. Identify problems aieady encoontered and antic~ate chalenges in the imledate fuhle. Assess iramacotherapy use and problems.
Consider use or referral to more intensive treatment.

Adapted from: Fiore MC, Jaen C, Baker T, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services. Public
Health Service. 2008.
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Appendix D-1: Algorithm Permission
e
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https www.southern.edu owa ?ae=Item&a=Open&t=IP
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Joy Hamilton
To:

es o

R

r

h 1, ht

e

e
Tu~ ·1~ch 18

2014 6:44 PM

Thanks Mr. Hughes. This information will be included in my proposal to the Medical Director of the Southeast Region.

Joy Hamilton
From: Hughes, John R [john.hughes@med.uvm.edu]
Sent: Tuesday, March 18, 2014 8:06 AM
To: Joy Hamilton
SUbject: RE: Smoking Algorithm

No need to ask permission
From: Joy Hamilton [mailto:joyh@southern.edu]
Sent: Monday, March 17, 2014 5:01 PM
To : Hughes, John R
SUbject: Smoking Algorithm
Good Day Mr. Hughes,
My name is Joy Hamilton and rm currently perusing my Doctor of Nurse Practitioner degree at Southern Adventist
University. rm a primary care provider working at the Health Department in a rural community. My project involves a

practice change regarding smoking cessation in primary care.

My purpose for contacting you is to gain permission to include in a proposal for a practice change from

"An Algorithm for

Choosing Among Smoking Cessation Treatments" I have found the information concise and informative
If this would be a possibility for me to include this algorithm in my proposal it would be greatly appreciated
Thanking you in advance.
Joy Hamilton APN-BC
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Appendix D-2: Algorithm Permission
t
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j https:, twww.southern.edu o a . ae=Item&a=O en&t=IP 1.
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Joy Hamilton
To:

~ 1.

Tuesd~

AP<l 08 2014 4 :l6 PM

Hello,

My name is Joy Hamilton and rm currently pursuing my Doctor of Nurse Practitioner degree at Southern Adventist
UniVersity. rm a primary care provider working at the Health Department in a rural community. My project involves a
practice change regarding smoking cessation in primary care.
My purpose for contacting you is to gain permission to include in a proposal for a practice change the algorithm
from "Tobacco Cessation Algorithm.doc". I have found the information concise and informative which would be
appropriate in serving the underserved and uninsured population that we see here at the local Health Department
If this would be a possibility for me to include this algorithm in my proposal it would be greatly appreciated
Thanking you in advance
Joy Hamilton. APN-BC

From: Goldstein, Adam O.[adam_goldstein@med.unc.edu]

Sent: Tuesday, April 08, 2014 7:14 PM

To: Joy Hamilton
Cc: Ripley-Moffitt, Carol
subject: RE: Smoking Cessation Algorithm
Yes- please ensure Carol that it is ours though.
Ag
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Appendix D-3: Algorithm Permission
From: Joy Hamilton [mailto:joyh@southem.edu]
Sent: Tuesday, April 08, 2014 7:18 PM
To: Goldstein, Adam 0.
SUbject: RE: Smoking Cessation Algorithm
Thanks for the permission, however rm not too sure who carol is. I am writing form Dunlap, Tennessee and called
the number on the web site and spoke with Mark who gave me your contact information.
To give the appropriate credit for the algorithm, who should I list?
Thanks,
Joy Hamilton

:

51

0

I

s

rn

'I

101

Goldstein, Adam 0. [adam_goldstein@med.unc.edu1
To:
Cc:

caro

e

ff 1

e

n'
Tuesday Ap<i 08 2014 ~20 PM

Carol is the Program Director of our Nicotine Dependence Program. I just want to be sure you are using the
correct algorithm. She can approve tomorrow.
Thanks!

Ag
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Algorithm D-4: Algorithm Permission
Rep

~E

Reply All

S

Forward

~•

o~ 1ng Cessation

.

~ ~

Ale n in

Ripley-Moffitt, Carol [carol_ripley-moffitt@med.unc.ed ...
To:

dam 0.

,m_

e

c.e

1uy

,,mu o
Wednesda)I Apr 09 2014 S 37

• 'lou replied on 4/9/2014 9:34 AM.

Joy, can you please send a copy of the algorithm and where you obtained it. If it is from a textbook, we may
need to get publisher's permission.

• •oy I lon11

1
Wednesdoy

O!I 2!ll4 kU

There was no web site ...just that 'tobacco cessation algorithm.doc' listed and the algorithm was there with the UNC info on top.
connected to any web site. Only 2 pages. Did you access it and see the algorithm rm referring to?

n was not

• Ripley-Moffitt, Carol [carol_ripley-moffitt@med.unc.edu]
Can you send me a copy or the address of the website?

Wednesday AP"

This was at the bottom of the page. tobacco cessation algorithm.doc
It's only a pdf with the UNC information on the top.
Thanks

2!ll4 34

,1
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Appendix D-5: Algorithm Permission
p
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Ripley-Moffitt, Carol [carol_ripley-moffitt@med.unc.ed ...
To:
09 2014 L26 PM

• Vou replied on 4 '9. '20141·28 PM.

Is there any way you can send me a copy, i.e. scan into a pdf or send as a document?
This does not sound familiar to me and it may be from another UNC department. If I could see tne UNC
information, as well as the algorithm that would help.
How did you come across this?
From: Joy Hamilton [mailto:joyh@southern.edu]
Sent: Wednesday, April 09, 2014 12:13 PM
To: Ripley-Moffitt, Carol
Subject: RE: Smoking Cessation Algorithm
There was no web site ...just that 'tobacco cessation algorithm.doc' listed and the algorithm was there with the UNC
info on top. It was not connected to any web site. Only 2 pages. Did you access it and see the algorithm rm
referring to?
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Appendix D-6: Algorithm Permission
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From: Ripley-Moffitt, Carol [carol_ripley-moffitt«Pmed.unc.edu]
Sent: Wednesday, April 09, 2014 1:45 PM
To: Joy Hamilton
subject: RE: Smoking Cessation Algorithm

Ok, as I suspected, this is from UNC Internal Medicine and is quite old, 2007. In addition, it references
materials to give to patients that may no longer be in print. I would recommend a more recent article and
diagram such as:
htto://ac.els-cdn.com/S074054nl3000342/l-s2.0-SQ74054721300Q342-main.odf? tid=3ea04c08-cOQe=lle380e6-00000aacb362&acdnat=l397065496 79a2ce3cle308369494799lf764al5d9
or you can certainly use the UNC model, and substitute titles for available educational materials
Good luck on your project, and let me know if you have questions,
Carol

l
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Appendix E: Proposal Acceptance - first phase

Joy Hamilton [Joy.Hamilton@tn.gov]
To:

From: Allyson Cornell
Sent: Wednesday, April 23, 2014 12:18 PM
To: Joy Hamilton
Subject: RE: Practice Change Proposal Revised
Joy,
I think this is a great proposal. I know you put a lot of time and work into creating this, and I definitely think this
could benefit our patients in their attempts to stop smoking. I will definitely forward this on to Dr. Beville, Medical
Director of Community Health Services, for her review. I also think the information you have collected, regarding
tobacco cessation, would be great to share at our next primary care meeting with all our primary care providers.
Thank you so much,
Dr.Cornell
Allyson Cornell M.D.
Regional Medical Director
Tennessee Department of Health, Southeast Region
540 Mccallie Avenue
Suite 450
Chattanooga, Tennessee 37402
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Sequatchie County Health Department
Tobacco Cessation Algorithm

No
No action.
Document in progress
notes
Screen in 12 months.

Precontemplation

Give patient
"Quitting Smoking"
From UTD/Quitine

Contemplation

Give patient "You Can Quit"
folder/ "Assisting pts with
smoking cessation" UTD and
review

Motivate to quit with "5 R's"
RELEVANCE
RISKS
REWARDS
ROADBLOCKS
REPETITION

Preparation

Action

Give patient "Assisting pts with smoking
cessation" UTD. Review Cessation Materials and
Resources

ASSIST to quit:
Counsel/Educate about quitting, assess desire for
NRT, alert to other cessation resources

Preparation: Set quit
date in next 2 weeks

Action: Quit
today

RX for Nicotine Patch +/- short acting nicotine
product (gum, lozenge, inhaler)
+/- Bupropion
(Consider varenicline ifNRT failed)

ARRANGE FOLLOW UP:
Recommend I mo & 3 mo PCP
Schedule call approx I week after appt
or quit date

If counseled 3-10 minutes, mark 99406 and ICD-9 "305.1" on billing sheet
If counseled> I0 minutes, mark 99407 and ICD-9 "305.1" on billing sheet

Maintenance

Give patient
"Preventing and
Managing relapse in
smokers" UTD
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Stages of change
Precontemplation - not thinking about quitting over the next 6 months
Contemplation - thinking about quitting over the next 6 months
Preparation - thinking about quitting within in the next 30 days
Action - actively trying to quit
Maintenance - no tobacco use in last 6 months

Pharmacotherapy for Smoking Cessation
Trade Name
Nicoderm CQ®;
Nicotine patch

Rx
Nicotine gum
OTC
Nicotine lozenge
OTC

Habitrol®; Prostep®

21 mg/d for 6 weeks

Full Dose/Duration

Then 10 mg x 2 wks, then 5

hrs/d)

mg x2 wks

Nicorette®

Start on quit date.

1 tab/hr for 6 wks, then 1

< 25 cig/day use 2 mg tab

tab/2 - 4 hrs for 2 wks, then 1

Commit®

~ 25

tab/4 - 8 hrs for 2 wks

Nicotrol NS®

Rx

cig/day use 4 mg tab

1 to 2 doses/hr (most need

Continue for 6 - 8 wks, then

minimum of 8 doses/day)

taper gradually over 4 - 6 wks

10 mg cartridges used over
Nicotine inhaler

Rx

Nicotrol Inhaler®

Average Cost

Then 14 mg/d for 2 wks, then
7 mg /d for 2 wks

15mg/d for 6 weeks (16

Nicotrol®

Nicotine nasal
spray

Starting Dose

$4.00/d, $120/mo

$5.50/d, $165/mo
$6.00/d, $180/mo
$6.60/d, for low use.
$17.00/d max
usage.
$6.50 /d, low use.

20 mins (6 to 16 cartridges

At least 6 cartridges/d for 3 -

per day).Tx for 3 mo then
decrease use over 6-12

cartridges/d

$17.00/d max usage

12 wks; max of 16

weeks.
Bupropion SR;
Bupropion XL

Rx
(avoid w/ sz hx)
Varenicline

Rx

Zyban®;
Wellbutrin SR®;
Wellbutrin XL®

Chantix®

Start 2 weeks before quit

Continue 150 mg BID for 7 to

date; 150 mg QD for 3

12 weeks

$2.50/d, $72/mo

days; then BID-spaced 8
hrs
Start 1 week before quit

Continue 1 mg BID weeks 2

date; Days 1-3

through 12; may continue an

=0.5mg
QDay, days 4-7 =0.5 mg
BID

additional 12 weeks if
necessary

-$4.60/d, $138/mo
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Common Adverse Effects to Smoking Cessation Products
Nicotine Patch

• Local skin
irritation
• Insomnia (w 24
hr dosing)
• Vivid dreams
• Sleep
Disturbances

•
•

Nicotine gum or

Nicotine nasal

lozenge

spray

Lightheadedness
Nausea and
vomiting

• Throat or mouth
Irritation

•
•
•

Hiccups
Indigestion
Jaw discomfort

Nicotine inhaler

•

Nasal or throat
irritation

• Throat or mouth
irritation

•

Sneezing
Coughing
Eye irritation
Runny nose
Patients with
allergies/asthma

•
•
•
•
•

•
•
•
•

should not use

•
•

Unpleasant taste
Cough
Rhinitis
Dyspepsia
Hiccups
Headache
Patients with
Asthma/CO PD
Should not use

Varenicline

Bupropion

•
•
•
•

Dry Mouth
Nausea
Insomnia
Constipation
• Agitation
• Change in mood
or behavior

contraindication:
seizure disorder

•
•

Insomnia
Headache
• Abnormal
dreams
• Nausea
• Vomiting
• Stomach upset
precaution: history
of psychiatric
illness
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CURRENT ISSUE
Tobacco use is the leading
preventable cause of death,
disease, and disability in the US.
About 1 in 5 adults smoke (45.3
million) and, although smoking
prevalence has declined from
20.9% in 2005 to 19.3% in 2010,
tobacco use is still the most
common cause of preventable
death and disease in the United
States (Centers for Disease
Control and prevention, 201 O).

A practice change is being proposed and
entails the following:
•

A request for the addition of the
patient's current smoking status as an
entity of the vital $igns.

•

An assessment to determine the
current stage of change according to
the Transtheoretical Model. Changing
or modifying a behavior that is
addictive or potentially harmful is
difficult for most people. The
Transtheoretical
Model
(TTM)
(Prochaska, Norcross, & DiClemente,
1994) incorporates a compilation of
previous
theories,
providing
a
framework for the stages of
progression when deciding to change a
problematic behavior.

•

Inclusion of an algorithm which will
serve as a guide for primary care
providers (PCPs) encompassing the
TTM.

LOCAL CHALLENGE
Primary care clinicians are in a
strategic position to help their
patients quit smoking. Currently,
the primary care sites have access
to the Quitline to distribute to
patients during encounters.
According to the 2008 New
Guideline on Treating Tobacco use
and Dependence, increasing
evidence shows that screening
and assessment practices such as
expanding vital signs to include
tobacco-use status, or other
reminder system to ask about
smoking significantly increase the
rate of clinician intervention.
Based on recent observations, the
current recommended approach
of the Quitline surveys with the
suggested interventions have
seemingly appeared to
inadequately reduce tobacco
usage at the primary care sites.

These three components of the proposal
would be in addition to the already
established QuitLine that is currently being
utilized.
The goal of this practice change would be to
provide improved patient care by increasing
provider's adherence to the recommendations of
a clinical practice guideline for the assessment
and treatment of smoking cessation in the
primary care setting.

TENNESSEE DEPARTMENT OF HEALTH
Bureau ol Heellh Services

ADOLESCENT/ADULT PHYSICAL EXAMINATION (11 years and older)
ll~Oft(If IPPUCeble)

I PCP:

provided by:

I LMP:

CHIEF COllPl.AINT:

VITAL SIGNS:

Ht.

ROS

·--·~

Wt.

N

AB

BMI

Temp

Pulse

...... History & Allergles ~
0

Comments:

BP

Resp

lmmunlDllone Aa...Md 0

1. Gener.i
2. E...,

3. ENT/mouth

4. Rao
5. CV

6. GI

7. GU

8. M111c:1*-llt111111
9. Skin
10. BrMll
11.
12. Endoc:tlne
13.
14 .

15. Psych

'

Currently, the certified nurses' assistance gets the vital signs and records them in their appropriate slots.

TENNESSEE DEPARTMENT OF HEALTH
Bureau of H..nh SeNtcee
fobacco use
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PCP:

UIP:
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Sequatchie County Health Department
Tobacco Cessation Algorithm

No

Yes

No action.
Document in progress
notes
Screen in 12 months.

Precontemplation

Give patient
"Quitting Smoking"
From UTD/Quitine

Contemplation

Give patient "You Can Quit"
folder/ "Assisting pts with
smoking cessation" UTD and
review

Motivate to quit with "S R's"
RELEVANCE
RISKS
REWARDS
ROADBLOCKS
REPETITION

Preparation

Action

Give patient "Assisting pts with smoking
cessation" UTD. Review Cessation Materials and
Resources

ASSIST to quit:
Counsel/Educate about quitting, assess desire for
NRT, alert to other cessation resources

Preparation: Set quit
date in next 2 weeks

Action: Quit
today

RX for Nicotine Patch +/- short acting nicotine
product (gum, lozenge, inhaler)
+/- Bupropion
(Consider varenicline ifNRT failed)

ARRANGE FOLLOW UP:
Recommend I mo & 3 mo PCP
Schedule call approx I week after appt
or quit date
If counseled 3-10 minutes, mark 99406 and ICD-9 "305.1" on billing sheet
If counseled >10 minutes. mark 99407 and ICD-9 "305.1" on billiniz sheet

Maintenance

Give patient
"Preventing and
Managing relapse in
smokers" UTD
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Stages of change

Precontemplation - not thinking about quitting over the next 6 months
Contemplation - thinking about quitting over the next 6 months
Preparation - thinking about quitting within in the next 30 days
Action - actively trying to quit
Maintenance - no tobacco use in last 6 months

s

c

Ph arm a coth erapy f or mok"mg essaf ion
Trade Name
Starting Dose
Full Dose/Duration
Nicoderm CQ®;
Nicotine patch

Rx
Nicotine gum
OTC
Nicotine lozenge
OTC

Habitrol®; Prostep®

7 mg /d for 2 wks
Then 10 mg x 2 wks, then 5

hrs/d)

mg x2wks

Nicorette®

Start on quit date.

1 tab/hr for 6 wks, then 1

< 25 cig/day use 2 mg tab

tab/2 - 4 hrs for 2 wks, then 1

Commit®

!: 25 cig/day use 4 mg tab

tab/4 - 8 hrs for 2 wks

1 to 2 doses/hr (most need

Continue for 6 - 8 wks, then

minimum of 8 doses/day)

taper gradually over 4 - 6 wks

Nicotine nasal
spray

Then 14 mg/d for 2 wks, then

21 mg/d for 6 weeks
15mg/d for 6 weeks ( 16

Nicotrol®

Nicotrol NS®

Rx

10 mg cartridges used over
Nicotine inhaler

Rx

20 mins (6 to 16 cartridges
Nicotrol Inhaler®

Average Cost
$4.00/d, $120/mo

$5.50/d, $165/mo
$6.00/d, $180/mo
$6.60/d, for low use.
$17.00/d max
usage.
$6.50 /d, low use.

At least 6 cartridges/d for 3 -

per day).Tx for 3 mo then

12 wks; max of 16

decrease use over 6-12

cartridges/d

$17.00/d max usage

weeks.
Bupropion SR;
Bupropion XL

Rx
(avoid w/ sz hx)

Zyban®;
Wellbutrin SR®;
Wellbutrin XL®

Start 2 weeks before quit

Continue 150 mg BID for 7 to

date; 150 mg QD for 3

12 weeks

days; then BID-spaced 8
hrs
Start 1 week before quit

Varenicline

Rx

Chantix®

$2.50/d, $72/mo

date; Days 1-3

=0.5mg
=0.5 mg

Continue 1 mg BID weeks 2

-$4.60/d, $138/mo

through 12; may continue an

QDay, days 4-7

additional 12 weeks if

BID

necessary

Common Adverse Effects to Smoking Cessation Products
llcotine Patch
• Local skin
irritation
• Insomnia (w 24
hr dosing)
• Vivid dreams
• Sleep
disturbances

Nicotine gum or
lozenge
• Lightheadedness
• Nausea and
vomiting
• Throat or mouth
Irritation
• Hiccups
• Indigestion
• Jaw discomfort

Nicotine nasal
spray
• Nasal or throat
irritation
• Sneezing
• Coughing
• Eye irritation
• Runny nose
• Patients with
allergies/asthma
should not use

Nicotine inhaler

•

•
•
•
•
•
•
•

Throat or mouth
irritation
Unpleasant taste
Cough
Rhinitis
Dyspepsia
Hiccups
Headache
Patients with
Asthma/COPD
Should not use

Bupropion

•
•
•
•

Dry Mouth
Nausea
Insomnia
Constipation
• Agitation
• Change in mood
or behavior
contraindication:
seizure disorder

Varenicline

•
•

Insomnia
Headache
• Abnormal
dreams
• Nausea
• Vomiting
• Stomach upset

precaution: histol)
of psychiatric
illness
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SUMMARY

Tennessee Department of Health Mission: To protect, promote, and improve the health
and prosperity of people in Tennessee.
Increasing evidence shows that screening and assessment practices such as expanding
vital signs to include tobacco-use status or other reminder system to ask about smoking
significantly increases the rate of clinician intervention.
The primary care setting is an ideal location to promote smoking cessation through
counseling and pharmacological aids. The US Preventive Services Task Force
recommends asking about tobacco use in all adults which may be accomplished by using
the 5-A model to assist PCP's implement Tennessee Department of Health's cessation
protocol. This system encourages clinicians to ask patients about their smoking status,
advise smokers to quit, assess their readiness to quit, assist them with their smoking
cessation effort, and to arrange for follow-up visits or contact (Fiore, M.C., Jaen, C., &
Baker, T., et al., 2008).
Patients who use tobacco but are unwilling to quit should be approached with the "5 R's"
of motivational intervention (Relevance, Risks, Rewards, Roadblocks, and Repetition)
(Fiore, M.C., Jaen, C., & Baker, T., et al., 2008).
The developed evidence-based treatment protocol algorithm is an easy-to-follow tool that
facilitates the incorporation of smoking cessation counseling during patient encounters.
During brief encounters, this algorithm may provide a concise pathway for providers to
follow in addition to the ability to bill for reimbursable services using the outlined CPT
codes (CPT, 2014).
Regarding cost, these three components of the proposal would eventually prove to be
perhaps a cost benefit in terms of a decrease in tobacco usage and consequently a
reduction in tobacco related illnesses and diseases due to the easy accessibility to the
providers. The projected miniscule cost on acceptance of this proposal may entail
obtaining additional resources from the CDC's publication department regarding
handouts or brochures for encouraging and maintaining smoking cessation in addition to
the QuitLine.
This project manager is respectfully seeking permission to implement the above practice
change proposal at all three primary care sites for a pilot study for approximately six

PRACTICE CHANGE
months. To determine efficacy of this practice change proposal, a follow-up six months
"Patient Tobacco Survey" would also be requested to then be evaluated by the
appropriate personnel deemed by the Southeast Regional Health Department.
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INTRODUCTION

The primary purpose of this project is to address the growing smoking epidemic concerlf in the
Southeast Region of Tennessee with adults aged 19 to 64 years who are uninsured who seek
care at the local health departments, specifically Sequatchie County Health Department. A
practice change is proposed and would entail a request for the addition ofthe patient's current
smoking status as an entity of the vital signs, and an assessment to determine the current stage
of change according to the Transtheoretical Model. Changing or modifying a behavior that is
addictive or potentially harmful is difficult for most people.

Evaluation Purpose
•

What does this evaluation strive to achieve?
Determine the efficacy of the added component to the vital signs section, and address
individual needs regarding stages of change relating to tobacco use.

•

What is the purpose of this evaluation?
The purpose of this evaluation is to attempt to reduce the amount of smokers who are
uninsured and live in rural communities. A good evaluation does not merely gather
accurate evidence and draw valid conclusions, but produces results that are used to make
a difference regarding smoking cessation in this community which is the ultimate goal

•

How will findings from the evaluation be used?
The ultimate purpose of a program evaluation is to use the information to improve
specific programs. The purpose initially identified early in the evaluation process should
guide the use of the evaluation results. The evaluation results can be used to demonstrate
the effectiveness of the program, identify ways to improve the current program, modify
program planning, and demonstrate accountability. Dissemination involves
communicating evaluation procedures or lessons learned to relevant audiences in a
timely, unbiased, and consistent manner. Regardless of how communications are
structured, the goal for dissemination is to achieve full disclosure and impartial reporting
(CDC, 2011).
Information will be disseminated among the other primary care sites in the Southeast
region and eventually across the state of Tennessee once deemed effective, valuable, and
successful.

Stakeholders
•

Who are the stakeholders for this evaluation?
The Regional Medical Director, the Medical Director of Community Health Services, and
the Director of Office of Quality Improvement.
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Tab\e F .1. Stakeholder Assessment and Engagement Plan
Stakeholder
Name

2.

Stakeholder
Category

Interest or
Perspective

Role in the
Evaluation
Gives the initial
and final
acceptance of the
Proposal
From a clinical
perspective, able
to view firsthand
the process from
the provider's
perspective
Collaborates with
the Medical
Directors of
Community
Health Services

Medical
Director of
Community
Health Services
Regional
Medical
Director

Primary
Stakeholder

Budget for
direct and
indirect costs

Secondary
Stakeholder

Works
closely with
the providers

Director of
Office of
Quality
Improvement

Tertiary
Stakeholder

Overall
Quality
improvement
for the
uninsured
patients

How and
When to
Engage
Initially and at
the completion
of the project
Throughout the
entire process

Initially for the
IRB process
and at the
completion

What is the goal?

The goal of this practice change would be to provide improved patient care by increasing
provider's adherence to the recommendations of a clinical practice guideline for the assessment
and treatment of smoking cessation in the primary care setting.

Need
• What is the need for what you are evaluating?
Reduction in tobacco use

Target Population
•

Uninsured or underinsured adults ages 19-64 years

Stage of Development
•

Is it in the planning or implementation stage?
This is in the planning stage
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Resources/Inputs

What resources are available to support what is being evaluated?
Time
Activities

•

What specific activities are undertaken (or planned) to achieve the outcomes?
Addition of tobacco use assessment to be included in the vital signs section of the
progress notes, inclusion of an assessment of change using the Transtheoretical Model,
and a concise algorithm to assist the provider at the point of care.

Outputs

•

What are some of the outcomes?
The increased number of calls to the QuitLine, or use of prescribed or OTC
medications.

Outcomes

•

What are the program's intended outcomes?
Increased knowledge and use of cessation services

•

What do you ultimately want to change as a result of your activities?
A reduction in tobacco related mortality and morbidity
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Logic Model

Promoting Smoking Cessation Among Young People and Adults
Logic model for promoting smoking cessation among young people and adults
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EVALUATION DESIGN

Stakeholder Needs
•

Who will use the evaluation findings?
The Regional Medical Director, the Medical Director of Community Health Services, and
the Director of Office of Quality Improvement.
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What do they need to learn from the evaluation?
The major issue is to approach tobacco users from different perspectives based on their
current stage of change. Determining if there is a reduction in tobacco use with the use of
the tobacco assessment in the vital signs section, and the appreciation of the concise
algorithm.
•

What do intended users view as credible information?
Evidence based research

Evaluation Design
•

What is the design for this evaluation?
The design for this proposal for a practice change would look retrospectively at the quit
rate prior and the quit rate after implementation of the change- both for a six month
period. This comparison would be determined by the tobacco surveys done on initial
and annual visits.

DATA COLLECTION
Data Collection Methods
•

Will new data be collected and compiled to answer the evaluation questions or will
secondary data be used?
New data will be collected for 6 months after implementation; secondary data will be
used for retrospective analysis and will also be obtained from the data base analysis
archived in the electronic system

•

What methods will be used to collect or acquire the data?
Tobacco surveys done annually and on initial encounters, unstructured self-report
utilizing a three question questioner, informal conversation done during the actual
encounters, and chart reviews.

•

Will a sample be used? If so, how will the sample be selected?
Purposive Sampling: Only smokers who are actually motivated and willing to quit
smoking assessed during encounters for follow up return visits, initial and annual visits.
Patients generally are open and honest in terms of their need or desire to quit.

•

How will the data be protected?
Charts are currently paper and with strict observance of HIPP A compliance with coding
in Excel utilizing a numerical and letter system to de-identify the charts on the project
manager's computer which is password protected. Charts are locked in an office every
evening and accessed by the office supervisor, medical director and project manager.
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Paper surveys will be distributed and a focus group interview will be used to obtain indepth information from a group of participants who have decreased their daily cigarette
amount to those who have gained the victory over tobacco use information of their
intervention. No more than ten open-ended questions will be used and presented to
approximately four to fifteen people who have never had prior interaction. A moderator
will be determined and an informed consent will be obtained prior to audio recordings.

5.

Data Analysis and Interpretation

Indicators and Standards
•

What are some measurable or observable elements that can tell you about the
performance of what is being evaluated?
During monthly or quarterly follow up visits, a reduction in the amount of cigarettes
smoked, or patients who have actually quit tobacco use. An assessment of
documentation compliance will be done to the other practitioners at their sites.

•

What constitutes "success"?
Determining an awareness of stage of change from the providers' perspective and to
assist with subsequent visits, and a reduction in the quantity of cigarettes smoked on a
daily basis to total abstinence.

Analysis
•

What method will you use to analyze your data
Content analysis will be used to analyze the qualitative data obtained from interviews,
focus groups, and comments written on participant surveys. Descriptive
Statistics of the data may include frequencies, means and summary statistics. To identify
any significant changes in the tobacco survey and patients' smoking cessation status,
possible pre and post intervention measures would be analyzed with the paired t test.

Interpretation
•

Who will you involve in drawing, interpreting, and justifying conclusions?
The epidemiologist and the Director of the Office of Quality Improvement

6.

COMMUNICATING
•

What actions will be taken to promote evaluation use?
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Presentations and open discussions at the quarterly primary care meetings
•

How will evaluation findings be used?
After the pilot study, the amended progress notes with the algorithm will be a permanent
part of the records

•

Who is responsible for implementing evaluation recommendations?
The Regional Medical Director

Communication
•

What methods will you use to communicate with evaluation stakeholders?
A PowerPoint presentation at the quarterly primary care meetings.

7.

EVALUATION MANAGEMENT

.Evaluation Team
• Who will implement this evaluation?
Medical director, RN's, APN's and MD's
Roles and Responsibilities of the Evaluation Team Members
Individual
Medical Director

APN's/MD's
Charge Nurse/RN

Title or Role
Responsible for the
flow of activities in the
various primary care
sites
Primary Care
Practitioners
In charge of the
CNA's

Responsibilities
Oversees the clinical aspects for
providers
Point of care services
Oversees the CNA's and their
documentations

Data Collection Management
•

What data will be collected?
Comparing the results of the Tobacco Survey before and after the implementation of the
proposed practice change in the electronic system

•

What activities are needed to carry out the data collection successfully? When should
each of these activities be completed?
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After six months of the pilot study, a comparison will be made to determine the efficacy
of the change in the progress notes, and a formal discussion with the providers to assess
the feasibility of the proposed change.

Data Analysis Management
•

What data will be analyzed, how, and when?
Content analysis will be used to analyze the qualitative data obtained from interviews,
focus groups, and comments written on participant surveys. The content analysis will
determine the specific concerns for the practice change, using a simple, systematic,
verifiable process. Each interview, focus group discussion and participant survey
comment will be transcribed and each line numbered.

Table F.7. Data Analysis Plan
Analysis to Be Performed

Data to Be
Analyzed

Person(s)
Responsible

Content Analysis

Tobacco surveys

Project manager

Correlation procedures

Information gained
from the providers

Project manager
and Medical
Director

Due Date

Communicating and Reporting Management
•

What are the target audiences for reporting the progress made on the evaluation and/or
evaluation findings?
MD's, APN's, RN's, and the Regional Medical Director

•

What is the purpose of the communications with this audience?
To ensure knowledge of the current evidence based information for assisting and
empowering our smoking population

•

What is the most appropriate type of communication method to use with this audience,
for this purpose?
Open discussions, oral presentations, at the quarterly primary care meetings

•

When will the communication take place?
Summer of 2014

Timeline
•

When will planning and administrative tasks occur?
After IRB approval
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When will any pilot testing occur?
Once approval of the practice change has been determined

•

When will formal data collection and analysis tasks occur?
After approximately 6 months

•

When will information dissemination tasks occur?
After review and discussion of the proposal, acceptance and then implementation

Evaluation Budget
•

What is the cost for this evaluation?
The projected miniscule cost on acceptance of this proposal may entail obtaining
additional resources from the CDC's publication department regarding handouts or
brochures for encouraging and maintaining smoking cessation in addition to the
QuitLine. Additional costs may also include reprinting charts, surveys, questioners and
additional personal time by the project manager.

